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ABSTRACT 
Between and inclusive of the years 1975-1989 two hundred and thirty nine patients attending 
Groote Schuur Hospital and the Associated Teaching Hospitals of the University of Cape Town 
have been retrospectively identified as having neurocysticercosis. One hundred and twenty 
three (51.46%) were children 12 years of age or younger. Fourteen (5.86%) were adolescents 
between and inclusive of the ages 13 to 19 years. One hundred and two (42.68%) were adults 
20 years of age or older. Two hundred and twelve (88.7%) of these patients were African 
almost exclusively belonging to the Xhosa speaking peoples and coming from or originating from 
the Eastern Cape homeland regions of the Transkei and Ciskei. 
Although the clinical features of neurocysticercosis are protean these patients were divided into 
three clinical groups - a seizure group, a raised intracranial pressure group and an asymptomatic 
group. One hundred and ninety patients (79.5%) presented with seizures alone or in 
combination with other neurological deficit. Eighty six patients (35.9%) presented with features 
of raised intracranial pressure due to hydrocephalus in 32, due to focal space demanding lesions 
in 4 and due to multifocal cysticercal encephalitis in 50. Ten patients (4. 1 %) were 
'asymptomatic' and were found to have neurocysticercosis following on computerised 
tomography (CT) scan done for investigation of head injury. 
Using radiological criteria 11 6 patients in this series were found to have cysticercal encephalitis, 
66 with focal encephalitis and 50 as noted above with multifocal encephalitis. 
The vast majority of the 50 patients with multifocal encephalitis were found to be children 1 2 
years of age or younger. There were 44 children compared to 2 adolescents and 4 adults. The 
adults were all younger than 30 years of age. The clinical radiological laboratory and 
electroencephalographic findings of these 50 patients are reviewed and discussed. 
Twenty nine of these 50 patients formed part of an open therapeutic study on the use of 
Praziquantel (a pyrazinoisoquinoline derivative) in the treatment of cysticercosis. The other 
twenty one of these 50 patients had not been treated with Praziquantel and their case histories 
xiii 
were reviewed retrospectively. 
Although matched the numbers that were followed from both the prospective (Praziquantel) 
group and in particular the retrospective (non-Praziquantel) group were far too small for any 
valid comparisons and conclusions concerning Praziquantel therapy in patients with multifocal 
cysticercal encephalitis. 
xiv 
AIMS 
1. To review and record the case histories of patients with neurocysticercosis who 
attended the Teaching Hospitals of the University of Cape Town between and inclusive 
of the years 1975-1989. This was done in order to categorise. 
a. the racial distribution of these patients 
b. the districts of origin of these patients 
c. the age distribution of these patients 
d. the distribution of these patients in three major clinical groups consisting of: 
i. seizure group 
ii. a raised intra-cranial pressure group; and 
iii. an asymptomatic group 
2. To identify those patients who presented with raised intra-cranial pressure or generalised 
encephalopathy and whose computed tomographic scans showed features of multifocal 
cysticercal encephalitis. this was done in order to categorise: 
a. the age distribution of these patients 
b. the sex distribution of these patients 
c. the clinical findings, the radiological findings, the laboratory findings, the 
serologic findings and the electroencephalographic findings in these patients. 
3. To record the response to treatment in the acute encephalopathic phase of multifocal 
cysticercal encephalitis in patients from: 
i. a retrospective group treated with corticosteroids and anticonvulsants 
ii. a prospective group treated with corticosteroids, anticonvulsants and 
Praziquantel (a pyrazinoisoquinoline derivative). This was done in order to 
categorise: 
the efficacy or not of corticosteroids in controlling the cerebral oedema 
of multifocal cysticercal encephalitis 
the benefit or not of adding Praziquantel to the therapy of these patients 
4. To record the long-term follow-up of patients with multifocal cysticercal encephalitis in 
both these retrospective and prospective groups in order to categorise if possible: 
xv 
a. The outcome and 'natural history' of multifocal cysticercal encephalitis in the 
corticosteroid treated retrospective group 
b. The effect, if any, on the prognosis of patients with multifocal cysticercal 
encephalitis treated with Praziquantel in addition to corticosteroids. 
PART t 
NEUROCYSTICERCOSIS 
LITERATURE REVIEW OF SELECTED TOPICS 
INTRODUCTION 
Cysticercosis, a parasitic infestation of great importance in man, is due to the invasion of human 
tissue by the larvae of the tape worm Taenia solium. The disease has a worldwide distribution 
but is most prevalent in developing countries (Marques-Monter 1971; Mahajan 1982). In these 
endemic regions cysticercosis constitutes a major health problem, because of the large numbers 
of people infected. It is the commonest parasitic infestation of the central nervous system 
producing significant morbidity and mortality (Trelles and Trelles 1979; Sotelo 1988). In 
addition to the severe health and economic problems created by the human disease, 
cysticercosis of the more usual intermediate host, the domestic pig, also results in large 
economic losses due to wastage of the infected meat or 'measly pork' (Velasco-Suarez et al 
1982; Acevedo-Hernandez 1982). 
In recent years, increased awareness of the prevalence and importance of this condition has 
developed with the dramatic improvement in diagnosis afforded by the development of 
Computerised Tomographic (CT) scanning of the brain (Minguetti and Ferreira 1982, Mazer et al 
1983; Rodriquez-Carbajal et al 1987). CT scanning of the brain in conjunction with improved 
serologic techniques has allowed better appreciation of the wide spectrum of clinical 
symptomatology produced by this disease (Chang et al 1988). Added impetus to the 
importance of early diagnosis is given by the recent advances in medical treatment of 
cysticercosis which may in the individual patient significantly reduce morbidity and improve 
prognosis (Vascoucelos et al 1987; Sotelo et al 1988). Perhaps of even greater importance 
would be the identification in endemic areas of populations at risk. Using appropriate serologic 
techniques, field trials would presumably identify the enormity of the problem and the socio-
economic value of educating these communities and instilling the need to improve both 
sanitation and farming methods (Schenone et al 1982). 
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EPIDEMIOLOGY 
The recognised endemic regions of the world are those areas where free range pig farming is 
practised by people who do not ensure adequate sanitation and thus effective removal of human 
excreta from their environment (Figure 1). Voluminous literature on the subject of cysticercosis 
has been published by health care professionals in the countries of Latin America (Schenone et 
al 1982). In particular, there are numerous publications from Mexico where the disease is 
extremely prevalent in certain regions (Sotelo et al 1985a; Grisolia and Wiederholdt 1982; 
Lombardo and Mateos 1961 ). Other well known endemic regions in Asia are India (Wadia et al 
1988; Vinayan et al 1977; Balasubramaniam et al 1971) as well as the Far East in particular 
China (Trelles and Trelles 1979; Feng 1987), Korea (Chang et al 1988), Indonesia (Subianto et 
al 1978) and Thailand (Trelles and Trelles 1 979). The endemic regions of Europe are the Slav 
countries of Eastern Europe such as Poland (Stepien 1962) and Rumania (Arseni and Cristesau 
1972) as well as the Mediterranean countries such as Spain (Lobato et al 1981 ). In Africa the 
frequency of taeniasis and cysticercosis due to taenia solium varies widely from country to 
country being reported infrequently from Kenya (Nelson et al 1965) but more frequently from 
Zimbabwe (Gelfand and Jeffrey 1973) and South Africa (Heinz and Klintworth 1965; Powell et 
al 1966; Tuch and Saffer 1984; Thomson et al 1984; Van Dellen and McKeown 1988). 
During the era of British rule in India cysticercosis was well recognised in soldiers returning to 
Great Britain after tours of duty in that country (MacArthur 1934). In more recent times with 
the increase in tourism and immigration the people of the more affluent countries of Western 
Europe and North America are at greater risk for the development of the disease (Earnest et al 
1987). 
AETIOLOGY - LIFE CYCLE 
To understand the pathogenesis of human cysticercosis the life cycle of the cestode Taenia 
solium must be reviewed (Figure 2). Man is the only definitive host of this parasite and usually 
harbours a single adult worm in the small bowel where it may live for many years producing few 
if any symptoms of gastro- intestinal discomfort. In Taeniasis (infestation due to adult Taenia 
Solium), the tape worm, may reach lengths of 2-7 metres and 
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5 
consists of a minute head or scolex, a short non-segmented neck and a segmented body or 
strobilia. These segments or proglottides which may number up to one thousand, mature and 
enlarge as they grow distally. They are hermaphroditic and the distal sexually mature ones may 
contain thirty to fifty thousand fertile ova each. These distal gravid proglottides when shed are 
passed with the faeces either intact or ruptured (Marquez-Monter 1971; Trelles and Trelles 
1979; Olive and Angulo-Rivero 1962). 
The expelled ova under conditions of poor sanitation will contaminate the environmental soil and 
vegetation and may be spread over large areas by insect and bird vectors as well as possibly by 
the wind as has been demonstrated in the case of the ovine (sheep) tape worm (Gemmell and 
Lawson 1982). The survival of these ova even in adverse climatic conditions is ensured by their 
tough surrounding membrane (Laclette et al 1982). 
Should the usual intermediate host, the domestic pig, ingest contaminated faeces or vegetation, 
porcine cysticercosis results. The outer membranes of the ova are digested by the gastric juices 
and the released oncospheres (embryos) penetrate the ileal wall gaining access to the vascular 
and lymphatic channels by which means they are distributed to the various host tissues. The 
small oncospheres after lodging in the distal capillaries penetrate the vascular wall and enter the 
adjacent tissue. The tissues most commonly involved are the muscles, subcutaneous tissues 
and the brain. Over a period of 9-10 weeks the oncospheres invaginate and encyst forming the 
'bladder worms' or larval cysticerci (Marques-Monter 1971; Trelles and Trelles 1979). These 
cysticerci remain viable in the host tissues for variable periods of time surviving on occasion for 
many years. 
If the infected meat or 'measly pork' from a slaughtered pig is then eaten by man in an 
undercooked state, Taeniasis results. The ingested larval cysticerci are activated by the bile and 
pancreatic juices in the duodenum and evagination of the scolex occurs (Canedo 1982). The 
evaginated scolex adheres to the mucosa of the small bowel by means of its hooklets and over 
some months the adult tape worm with its gravid proglottides develops. The life cycle of Taenia 
solium is completed. 
6 
Man can, unfortunately, also function as an intermediate host in the life cycle of Taenia solium. 
Human cysticercosis occurs when vegetation or water contaminated by the ova of Taenia 
solium is ingested . Perhaps the well-known perverted appetite (Pica) of small children leads to 
compulsive eating of dirt (Geophagia) and results in the heavy larval infestation found in some 
patients. Pica is thought to be more common in malnourished children particularly those with 
iron deficiency anaemia (Lukens 1984). External auto-inoculation with Taenia ova may result 
from anus to finger to mouth contamination in people with taeniasis. Internal auto-inoculation is 
also thought to possibly occur when gravid proglottides are regurgitated into the stomach by 
reverse peristalsis, allowing digestion of the outer membranes of the ova and activation of the 
embryos (Trelles and Trelles 1979; Olive and Angulo-Rivero 1962) . Although (as noted in the 
pig), all tissues are at risk, it is the brain, muscles, and subcutaneous tissues that are the most 
commonly infected in human cysticercosis which may be asymptomatic or symptomatic . 
Obviously unless cannibalism is practised the life cycle of Taenia solium is interrupted when the 
human becomes the intermediate host. 
PATHOGENESIS 
As mentioned previously once the solid hexacanth embryos or oncospheres have transversed 
the gut wall they are carried by the blood stream to the various body tissues in particular the 
central nervous system. Even congenital neurocysticercosis has been histologically documented 
in a 2 month old infant (Krivoy et al 1988) . Symptomatic cysticercosis can be sub-divided into 
4 groups. The first group consists of larvae in the central nervous system (neurocysticercosis); 
the second group comprises patients with larvae in sub-cutaneous tissues, muscles and viscera 
(disseminated cysticercosis); the third group consists of patients with larvae in the eyes and 
orbits (ophthalmocysticercosis); and the fourth group who have cysticercotic larvae in more 
than one of the above locations (mixed cysticercosis) (Zenteno-Alanis 1982) . Depending on 
where the oncospheres lodge in the nervous system two types of bladder worm or cysticercosis 
will develop (Rabiela-Cervantes et al 1982). 
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Figure 3 
Surgical specimen • Hemispherectomy for 
intractable epilepsy following an infarct in 
the territory of the right middle cerebral 
artery. lnfarcted hemisphere with 
subarachnoid/cortical mantle cysticercosis 
(white and black arrows) 
Figure 4 
Microphotograph demonstrating a degenerate 
cyst with numerous hooklets - histology from 
specimen shown in Figure 3. 
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The first type named cysticercus cellulosae is a semi-translucent or opalescent round or oval 
cyst. Contained within the thin uniform cyst wall is the invaginated scolex with its suckers and 
hooks which if ingested, while still viable, would evaginate and develop into the adult worm. 
The cysts of cysticercus cellulosae are usually small and vary in size from a few millimetres to 2 
centimetres and only very occasionally up to 4 ems. (Figure 3, Figure 4). Their small size 
appears to be the result of their location (1) in the confined subarachnoid spaces between the 
gyri of the cerebrum and the folio of the cerebellum (2), in the adjacent grey matter (3), in the 
deep end-arteriolar tissues of the internal capsule and the basal ganglia and (4) in the smaller 
recesses of the ventricles. These cysts, while the cyst wall is viable and intact, do not elicit an 
inflammatory reaction in the adjacent tissue and are usually asymptomatic irrespective of the 
viability of the scolex. On occasion however an exceptionally large viable cyst may produce 
symptoms and signs as the result of tissue compression and distortion (Berman et al 1981; 
Joubert and Van As 1990) . However, with the death of the cyst wall it is thought that the 
parasite's antigens leak out and produce an inflammatory/allergic response in the adjacent 
tissues resulting in the production of symptoms and signs (MacArthur 1934; Marquez-Monter 
1971; Trelles and Trelles 1979; Nash and Neva 1984). On the other hand some authorities 
believe that the enlarging cysts invoke the inflammatory reaction by immunological, chemical or 
mechanical means and that this inflammation produces the death and disintegration of the cysts 
(Rabiela-Cervantes et al 1982). Whatever the mechanism of inflammation, it seems that 
cysticercus cellulosae usually only become symptomatic when there is an inflammatory reaction 
in the surrounding tissue. The extent of this inflammatory response and the consequent clinical 
result depends on the location and the number of parasites in the brain. 
The second type named Cysticercus Racemosae is much less common and appears to evolve 
from cysticercus when this parasite is not confined and can enlarge in the larger subarachnoid 
spaces of the basal cisterns, insula and sylvian fissure as well as in the larger ventricular 
spaces. These cystic lesions range in size from 4-1 2 ems and range in shape from a single 
multilobulated cyst to a complex of multiple attached bladders resembling a bunch of grapes 
(Figure 5). These cysts have viable parasitic capsules but do not contain 
9 
Figure 5 
Surgical specimen - racemose cyst being removed 
from the Fourth Ventricle . 
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scoleces. Initially they may be free floating and may only produce symptoms of intermittent 
hydrocephalus due to intermittent obstruction of cerebrospinal fluid (CSF) pathways (Bickerstaff 
et al 1952). With time these cysts collapse and flatten becoming attached to the pia-arachnoid 
or ependyma producing repeated bouts of inflammation with the development of a thickened 
adhesive arachnoiditis and a granulomatous ependymitis. The extensive fibrosis produced by 
these inflammatory lesions results in either obstructive or communicating hydrocephalus as well 
as on occasion infarction of brain tissue due to the associated inflammatory endarteritis 
(Barinagarrementeria and Del Brutto 1989). 
Apparent intermediate forms of cysticerci, ranging from the cellulosa to the racemose form, 
were also found in nervous tissue as was the co-existence of both cellulosae and racemose 
forms in a single brain (Rabiela-Cervantes et al 1982) . 
Racemose cysts may also develop from Coenurus Cerebralis the larval stage of the dog 
tapeworm Multiceps Multiceps . These cysts contain numerous invaginated scolices and thus 
can be readily distinguished from the racemose form of cysticercosis. However, when 
degenerative changes occur in these cysts it becomes impossible to differentiate histologically 
the racemose cysts of either type of parasite . If, however, under these circumstances 
parenchymal cysts are present in addition, the likely diagnosis is that of cysticercosis (Kuper et 
al 1958; Bickerstaff et al 1952). 
PATHOLOGY 
The symptoms and signs presented by patients with neurocysticercosis are extremely varied and 
there are no clinically diagnostic neurologic syndromes. These facts are easily understood when 
the major factors governing the neuropathological changes are understood (Marquez-Monter 
1971; Trelles and Trelles 1979; Sotelo 1988) . 
These factors are: 
1. The number of the infesting parasitic larvae which may vary from one to several 
hundred. 
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Figure 6 
Autopsy specimen - Coronal section of the 
brain showing the presence of racemose 
cysts. 
1 . in the subarachnoid space of the 
basal cisterns and Sylvian fissures 
2. in the Third Ventricle 
• 
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2 . The neuroanatomic location of the parasite which to some extent depends on the 
amount of blood flow to the involved tissue. This is most commonly the subarachnoid 
space and the adjacent brain parenchyma and less commonly the deeper parenchyma 
and ventricles. All of these regions in varying combinations may be involved in some 
patients . 
3. The varying rate of evolution of the parasite or in other words the natural history of the 
disorder. This is largely unknown but appears to depend on the neuroanatomic location 
of the parasite, and the interactions at the parasitic host interface . These interactions 
are determined by peculiarities of the parasite as well as; 
4 . By the varied immune responses elicited in the host brain and meninges . These 
responses can range from immune tolerance to severe allergic inflammatory lesions with 
associated oedema and local involvement of blood vessels progressing to granuloma 
formation with gliosis/fibrosis and eventual calcification. 
5. The possible development of complications such as hydrocephalus, cerebral infarction 
and cerebral shifts and pressure cones which can only add to the variability and 
complexity of the clinical picture . 
Prior to the advent of CT scanning of the brain, the experience gained from autopsy and 
neurosurgical reports, although documenting the presence of parenchymal cysts, had 
emphasized the morbidity and mortality due to the racemose cysts in the larger subarachnoid 
spaces and ventricular systems (Cardenas 1962; Arana and Asenjo 1945; Bickerstaff et al 
1952; Kuper et al 1958) (Figure 6). Most of the deaths due to neurocysticercosis were related 
to the presence of these racemose cysts and the associated inflammatory fibrosis resulting in 
hydrocephalus, infarction or mass lesions. The cysts of the smaller cysticercus cellulosae which 
were located in the narrower subarachnoid spaces and ventricular recesses as well as in the 
brain parenchyma were found frequently at autopsy in 'asymptomatic' adults dying from other 
causes. Only minor inflammatory change with minimal pericyst parenchymal compression was 
found in these patients with cysticercus cellulosae. The evolutionary spectrum from viable 
cysticercus cellulosae through focal granuloma to focal calcific lesion was occasionally found in 
the same patient (Rabiela-Cervantes et al 1982). The parenchymal cysts, except for occasional 
Figure 7 
Microphotograph - Cysticercus 
cellulosae with marked inflammatory 
infiltration of the overlying pia-
arachnoid demonstrating the superficial 
position of the parasite in the cortical 
mantle. 
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Figure 8 
Microphotograph demonstrating endarteritis 
in cerebral tissue in the neighbourhood of a 
cyst 
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giant cysts were thought to produce no symptoms until evolution of the calcific foci with the 
adjacent neurons known to be potentially epileptogenic. Therefore, with the exception of this 
well known association of epilepsy and calcific foci seen on x-rays of soft tissues and skull, it 
was not until the use of CT scanning of the brain in endemic areas, that a previously seldom 
reported form of neurocysticercosis was recognised with increasing frequency. This is the 
cysticercosis cellulosae form of the parasite in the parenchyma and deep sulci of the cerebral 
and cerebellar hemispheres. This parenchymal form, has become established as an important 
form of symptomatic neurocysticercosis (Carbajal et al 1977; Handler and Mervis 1983; 
Minguetti and Ferreira 1983, Mazer et al 1983). Standard views and sections of the brain, as 
shown by CT scanning, by MR imaging and by routine autopsy demonstrate that the parasitic 
lesions appear to lie well within the brain substance. However it has been shown at autopsy 
that by careful dissection many of the cysts actually lie within the narrow subarachnoid spaces 
of the deeper cortical sulci and only displace or distort the adjacent grey matter. Thus although 
undoubted parenchymal lesions are found in the deep grey matter nuclei, in the internal capsule 
and in the brain stem it appears that many of the cortical grey matter lesions originate in the 
subarachnoid space of the sulci (Rabiela-Cervantes et al 1982; Lotz et al 1988) (Figure 7; 
Figure 8) . The sum of these sulcal and parenchymal lesions constitutes the most common form 
of neurocysticercosis (Carbajal and Duran 1982; Suss et al 1986). Whatever the precise 
neuroanatomical location of these 'parenchymal' lesions a severe inflammatory allergic type 
reaction may develop around the encysted embryos. There may be significant parenchymal 
involvement with a host tissue reaction of lymphocytes and plasma cells infiltrating the pericyst 
and capsular tissue. The surrounding brain parenchyma is oedematous with perivascular 
mononuclear cell infiltration (Madrazo et al 1983; Rangel et al 1987). 
These inflammatory oedematous lesions have aptly been labelled acute cysticercal encephalitis 
(Madrazo et al 1983). Acute cysticercal encephalitis may be: 1) focal either remaining 
asymptomatic or manifesting with seizures and/or focal neurologic deficit; or 2) multifocal and 
so extensive that severe diffuse cerebral oedema results with critically raised intra-cranial 
pressure (Rangel et al 1987). Associated meningeal reaction may be extensive enough to 
produce changes in the cerebrospinal fluid and qualify the inflammatory process for 
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classification as cysticercal meningoencephalitis. 
CLASSIFICATION NEUROCYSTICERCOSIS - PATHOLOGICAL, RADIOLOGICAL, 
CLINICAL 
Classifications of neurocysticercosis based on clinicopathologic manifestations are, due to the 
protean features of the disease, not easily conceived and are thus often incomplete, overlapping 
or cumbersome. Four classifications will be briefly described. In 1949 Stepein and Chorobski 
developed from their large series the following classification (Stepein and Chorobski 1949; 
Stepein 1962): 
Group 1: 
Group 2: 
Group 3: 
The parasitic cyst is single in most cases and produces the symptoms and signs 
of a space demanding lesion . 41 . 7 % of their cases were so classified. 
The parasitic cysts are numerous and produce cerebral swelling/oedema with 
symptoms of psychosis, dementia or raised intracranial pressure. This form of 
the illness was most common in children. 25. 7% of their cases were so 
classified. 
The parasitic cysts are located mainly at the base of the brain and cause chronic 
basal leptomeningitis and/or ependymitis with internal hydrocephalus and 
symptoms of raised intracranial pressure. 32.6% of the cases were so 
classified . 
This classification derived from a group of selected symptomatic neurosurgical patients 
as well as from autopsy material is perhaps not encompassing enough. Of interest the 
incidence of the various clinical features of the disease reported in these papers is 
markedly different from the incidence found in earlier reports of patients in Great Britain 
who were mainly ex-British Indian Army soldiers (MacArthur 1934; Dixon and 
Hargreaves 1944). Amongst these latter patients epilepsy was by far the most common 
symptom while symptoms and signs of raised intra-cranial pressure and focal 
neurological deficits occurred much less commonly. 
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Radiology 2 .. 
CT scan demonstrating a large right tempero-parietal 
infarct and a lacuna lateral to the head of the right 
Caudate Nucleus. Other CT scan views of this patient 
showed the presence of calcific foci. 
._ Radiology 1 
CT scan demonstrating hydrocephalus and a mass of 
racemose cysts in the left Sylvian Fissure. 
._ Radiology 3 
CT scan demonstrating the presence of generalised 
atrophy with scattered calcific foci. 
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With the advent of CT scanning more extensive classifications were proposed and Rodriguez-
Carbajal et al using their wide experience classified a large series of patients with 
anatomopathological and CT correlation (Carbajal and Duran 1982). 
1. Meningeal cysticercosis manifesting in the acute phase with meningeal enhancement 
followed by hydrocephalus in the chronic phase. Cerebral infarction due to involvement 
of basal and perforating blood vessels was also described. 17 .6% of their cases fitted 
into this category (Radiology 1 and Radiology 2). 
2. lntraventricular cysticercosis . Only 2.3% of their cases were so classified. 
3. Parenchymal cysticercosis was the most frequent localization involving 66.6% of 
their cases. Three different forms were identified: 
a. calcific foci solitary or multiple (Radiology 3) - these calcific foci represent dead 
calcified parasitic granulomata not to be confused with viable cysts containing 
calcified scoleces (Radiology 4) 
b. intracerebral cysts solitary or multiple (Radiology 4 and Radiology 5). 
c. 'granulomatous' cysticercosis in an acute encephalitic phase (Radiology 6). 
This type of lesion may also be single or multiple and occurred more frequently 
in children and adolescents. (As previously discussed there is pathologic 
evidence that many of the 'parenchymal' cyts and 'granulomata' are 
subarachnoid in the deep cortical sulci but even so the clinical effects result 
largely from parenchymal involvement). 
4. Mixed cysticercosis where parasites were found in various combinations of meningeal 
parenchymal and ventricular forms. 13.5% of their cases fitted into this category. 
This classification highlighted the importance of the various forms of 'parenchymal' 
cysticercosis which because of CT scanning could now be diagnosed prior to surgery or 
autopsy. These parenchymal lesions comprised 66.6% of the series a figure very similar to the 
one produced by the sum of Groups 1 and 2 of Stepein et al study i.e. 67.4% - a presumably 
similar group of patients. 
Radiology 5 .,._ 
CT scan (with contrast) demonstrating two 
posteriorly placed giant cysts . One of 
these is undergoing degeneration with an 
enhancing rim and pericyst oedema. [MRI 
of this patient demonstrated, in addition, 
the presence of a few smaller cysts). 
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;,'" 
..,_ Radiology 4 
CT scan demonstrating numerous 'parenchymal' 
cysts many of which contain calcified scoleces . 
,: ..,_ Radiology 6 
CT scan (with contrast) demonstrating 
the ring enhancing and homogeneously 
enhancing lesions of granulomatous 
cysticercosis (multifocal cysticercal 
encephalitis). 
Note the oedema of varying degree 
in the surrounding white matter. 
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A classification of 753 patients integrating CT and CSF findings with a view to identifying 
'active' and 'inactive' forms of neurocysticercosis for the purposes of therapeutic trials and 
research into the immunology of the disease was proposed by Sotelo et al (Sotelo et al 1985; 
Sotelo 1987): 
1 . Active disease 
a. Parenchymal cysts - 14.2% 
b. Encephalitis and vasculitis - 2.3% 
c. Arachnoiditis - 46.2% 
d. lntraventricular cysts - 0. 7% 
e. Spinal cysts - 0. 7% 
2. Inactive disease: 
a. Granulomas and calcifications - 57.6% 
b. Basal fibrosis - 3.8%. 
This classification although extensive and derived from a very large experience is unfortunately 
confusing especially with regard to assessing therapy in relation to the natural history of the 
disorder. It does not allow, in particular, for clear understanding of the term 'active disease'. 
'Viable' enlarging parenchymal cysts which elicit no inflammatory reaction and are quiescent 
and asymptomatic may continue to actively enlarge without producing an active inflammatory 
response in the host. These viable cysts may require different management from 'dying' cysts. 
The 'dying' or 'dead' cysts are actively eliciting an inflammatory response in the host with the 
producion of enecephalitis, vasculitis 3nd arachnoiditis i.e. active disease on the part of the host 
despite an inactive dead parasite. 
Another excellent paper by Stern attempts to surmount the inherent difficulties associated with 
an all-encompassing clinico-pathological classification. Although managing to reveal these the 
author does manage to categorise the various forms in an understandable if somewhat 
cumbersome and lengthy classification (Stern 1981 ). A summary of this classification follows. 
Category I 
Category II 
Category Ill 
Category IV 
Category V 
Category VI 
Category VII 
Category VIII 
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Diffuse Parenchymatous disease - larval death with inflammatory reaction 
producing toxic encephalopathy and meningitis 
Calcified larval form with seizures. 
Basilar adhesive and racemose form with arachnoiditis and 
hydrocephalus. 
Ventriculitis and hydrocephalus. 
lntra-parenchymal cysts as mass lesions - solitary or multifocal. 
Subarachnoid and cysternal cysts - focal symptomatology. 
Intra-ventricular cysts - solitary or multiple. 
Spinal forms. 
The author includes mixed and overlapping types in categories Ill, IV, VI and VII in a somewhat 
random fashion which only serves to stress the varied pathological findings that are possible in 
any one patient. 
However, many publications on the subject of neurocysticercosis confirm that despite the 
numerous possible pathological changes and protean clinical features the majority of patients 
present with problems related to seizures, to raised intracranial pressure, to localizing 
neurological deficits, to psychiatric disorders or to combinations of any or all of the above 
(Trelles and Trelles 1979; Sotelo 1988; Grisolia and Wiederholdt 1982 Lombardo and Mateos 
1961; Earnest et al 1987; McCormick et al 1982; Torrealba et al 1984; Bittencourt et al 1988; 
Shasha and Parmenter 1989; Loo and Braude 1982; Zenteno-Alanis 1982). Autopsy series 
(Rabiele-Cervantes et al 1 982) have shown that many people infected with neurocysticercosis 
are asymptomatic and the wide use of CT scanning in endemic areas is increasingly confirming 
this fact. 
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PART II 
NEUROCYSTICERCOSIS - TEACHING HOSPITALS, 
UNIVERSITY OF CAPE TOWN 
METHODS: 
Cases diagnosed as having neurocysticercosis while attending the University of Cape Town 
Teaching Hospitals between and inclusive of the years 1975-1989 were identified by review of: 
1 . The discharge diagnosis obtained from the Groote Schuur Hospital medical records. 
2. The listed diagnosis obtained from the records of the Groote Schuur Hospital Department 
of Neuroradiology. All the patients attending Somerset Hospital and those attending the 
Red Cross War Memorial Children's Hospital from 1975 to 1987 were traced in this way. 
3. The discharge diagnosis obtained from the Red Cross War Memorial Children's Hospital 
medical records for the years 1 988-1989 as CT scanning became available on these 
premises during this period. 
From amongst the case records that were still available for review 239 patients were accepted as 
having neurocysticercosis. 
neurocysticercosis were used. 
The following diagnostic criteria for the diagnosis of 
1. Diagnosis definite: (For a definite diagnosis at least one of the following criteria had to be 
present) 
a. Histologic confirmation of cysticercosis from biopsy or autopsy specimens. 
b. Positive titres of cysticercus antibodies in serum and or CSF of patients with 
compatible clinical and characteristic radiological features 
2. Diagnosis probable: 
Diagnostically characteristic CT scan features in patients from endemic regions in whom 
the evolution of the clinical and radiological features was compatible with such a 
diagnosis. 
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The charts of these selected patients were reviewed and data collected and stored 
regarding race, district of origin, age, sex, clinical features, cerebrospinal fluid findings, 
full blood counts, serum chemistry, radiologic investigations, electroencephalographic 
findings and serologic findings. 
Initially all these patients were classified according to the clinical format mentioned above 
i.e.: 1) those with seizures with or without other neurological problems; 2) those with 
symptoms and signs of raised intra-cranial pressure; 3) those who were 'asymptomatic' 
but were found to have neurocysticercosis on CT scan done for other reasons e.g. 
trauma. 
RESULTS 
Between and inclusive of the years 1975 - 1989 two hundred and thirty nine patients who 
attended Groote Schuur Hospital and the associated teaching hospitals of the University of Cape 
Town have been identified as having neurocysticercosis. From Graph 1 it can be seen that 
88.7% of these patients were African. Graphs 2 and 3 delineate the districts from which these 
patients came. 58.46% of the patients were referred directly from the rural regions of the 
Transkei and Ciskei. Another 36.52% came from the Western Cape. These patients were 
migrant labourers residing in the African townships and squatter camps of Greater Cape Town 
and its environs. Occasional African patients were referred for neurological investigation from as 
far afield as for example Malawi. 
From Graph 4 it can be seen that 51.46% of the patients were children, again largely Africans as 
shown in Graph 5. 
Prior to this review i.e. prior to 1975 only a few adult patients presenting with neurological 
problems had been diagnosed at Groote Schuur Hospital as having neurocysticercosis. However, 
in this series during 1975-76 although only four cases were diagnosed all were children. With 
the advent of CT scanning at Groote Schuur Hospital towards the end of 1977 there was a 
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marked increase in the number of patients diagnosed as having neurocysticercosis. From Graph 
6 it can be seen however that it was only from 1986 that per annum more adults than children 
were diagnosed with the disease. 1989 showed a massive increase in the number of adult 
patients. 
In this series there was no significant difference between the number of male (48.54%) and 
female (51.46%) patients. 
The clinical division of these 239 patients into 3 groups is tabulated below (Table I). Some of 
these patients were classified as belonging to both the seizure and the raised intra-cranial 
pressure groups. 
TABLE I : CLINICAL GROUPS 
GROUP I SEIZURES: = 190 
This group consists of patients presenting either with recurrent 
seziures (epilepsy) or recent onset of seizures ('acute seizures' 
i.e. initial seizure within the week prior to admission). 
Epilepsy only (adult 27, children 24) = 51 
focal neurology 
Epilepsy + dementia (adult 13, children 21 I = 34 
psychiatric 
Epilepsy + raised ICP (adult 8, children 22) = 30 
Acute seizure (adult 24, children 25) = 49 
Acute seizure + raised ICP (adult 4, children 22) = 26 
GROUP 2 RAISED INTRACRANIAL PRESSURE = 86 
Hydrocephalus (adult 26, children 6) = 32 
Space demanding mass lesion (adult 4, children 0) = 4 
Multifocal cysticercal encephalitis (adult 6, child 44) = 50 
GROUP 3 ASYMPTOMATIC (adult 10, children 0) = 10 
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DISCUSSION 
The great majority of these patients (88. 7%) were African. They came from amongst the 
different Xhosa speaking tribes of the Ciskeian and Transkeian homelands. In these rural areas 
free range pig farming is practised and sanitation is largely non-existent. It is therefore no 
wonder that cysticercosis is so commonly found amongst the Xhosa people of the Eastern Cape 
Province (Sasha and Pammenter 1989; Campbell and Farrell 1987). The large number of patients 
referred from the African townships and squatter camps of greater Cape Town where migrant 
workers and their family members who had originated from the Ciskei and Transkei. Only 3 
African patients in this series did not belong to the Xhosa nation and came from other areas -
Malawi, Namibia and Transvaal respectively. 
The large number of children in this series was partly due to the seriouness of the illness in many 
of them and until recently partly due to the absence of neurological investigative facilities at the 
referral hospitals in East London - Frere Hospital and Cecilia Makiwane Hospital. Presumably the 
presence of pica with geophagia in some of these children allowed for the very heavy infestation 
present in most of those referred directly from the Eastern Cape. 
Initially in this series more children than adults were diagnosed annually as having 
neurocysticercosis. However, more recently the numbers of adult patients with the disease have 
increased. By 1989 the adult patient numbers had markedly increased. This was probably related 
to the increasing influx of African labourers into the Western Cape. This adult patient 
preponderance is the more usual finding in many series reported from endemic areas and quoted 
in extensive review articles (Earnest et al 1987; McCormick et al 1982; Loo and Braude 1982). 
Seizures were by far the commonest clinical manifestation ( 1 90 patients) and presented as the 
only problem in 100 of these (51 adults, 49 children). That seizures are the commonest clinical 
manifestation of neurocysticercosis has been well documented (McArthur 1934; Arseni and 
Cristesau 1972; Bittencourt et al 1988). It is of interest to note that seizures plus raised 
28 
intracranial pressure and that seizures plus one or more of dementia, psychosis and focal 
neurological deficit occurred much more commonly amongst the children (65 children, 25 adults). 
The increased morbidity amongst the children in this series with seizures was probably due to the 
patient selection, in particular due to the selection of those children referred with raised 
intracranial pressure. 
The next most common clinical presentation was that of raised intracranial pressure which 
occurred in 86 patients. It is of interest to note the significant differences in the causes of raised 
intracranial pressure in children as compared to adults. Amongst the adults with raised 
intracranial pressure 26 had hydrocephalus, 6 had multifocal cysticercal encephalitis and 4 had 
focal space demanding lesions. Amongst the children (12 years or younger) on the other hand 
44 had multifocal cysticercal encephalitis whereas only 6 had hydrocephalus and there were no 
children with space demanding focal lesions large enough to produce recognised features of 
raised intracranial pressure. These differences in the causes of raised intracranial pressure in 
adults and children with neurocysticercosis have been noted previously (Hernandez and Garaizar 
1982a). 
Although only 1 0 asymptomatic adults in this series were discovered on CT scan of the brain 
done for other reasons, it is known from autopsy, radiologic and serologic studies done in 
endemic areas that there are many patients with neurocysticercosis who are asymptomatic 
(Rabiela-Cervantes et al 1982; Zenteno-Alanis 1982; Mazer et al 1983; Zini et al 1990). 
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PART Ill 
MUL TIFOCAL CYSTICERCAL ENCEPHALITIS 
METHODS 
From amongst the 239 patients with neurocysticercosis those with cysticercal encephalitis were 
selected using CT scan features which have been well described. Following contrast 
administration these features consist of a small ring enhancing or a small homogenously 
enhancing lesion (radiologically termed 'granuloma') with surrounding white matter oedema 
(Minguetti and Ferrreira 1983; Mazer et al 1983; Carbajal and Duran 1983; Sotelo 1987) 
(Radiology 6). These CT scan features have been correlated with the histologic findings of the 
encysted parasite surrounded by inflammatory exudate and oedema (Madrazo et al 1983; Rangel 
et al 1987). These 'granulomatous' encephalitic lesions may vary in number from a single lesion 
to many lesions, the term miliary being used to describe the latter (Sotelo et al 1 985). Prior to 
the use of CT scanning only the severe miliary forms were occasionally diagnosed antemortem in 
endemic areas. Ventriculography done in these patients demonstrated symmetrically swollen 
brains with slit ventricles and effacement of the cortical sulcal pattern (Stepien 1962). 
Using these radiologic criteria 116 patients (80 children, 36 adults) were identified as presenting 
the features of cysticercal encephalitis. Sixty six patients had five or less enhancing lesions on 
their presenting CT scans. For the purposes of this study these patients were defined as having 
focal encephalitis (Table 2). 
TABLE 2: FOCAL CYSTICERCAL ENCEPHALITIS 
C T scan findings: 
Granulomas with oedema (34 child, 27 adult) 
Enhancing cysts with oedema (0 child, 5 adult) 
Clinical features: 
Epilepsy alone (28 child, 25 adult) 
Epilepsy + (focal neuro/dement) (6 child, 4 adult) 
Epilepsy + mass effect + t ICP (0 child, 3 adult) 
66 patients 
61 patients 
5 patients 
53 patients 
10 patients 
3 patients 
29 
PART Ill 
MUL TIFOCAL CYSTICERCAL ENCEPHALITIS 
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From amongst the 239 patients with neurocysticercosis those with cysticercal encephalitis were 
selected using CT scan features which have been well described . Following contrast 
administration these features consist of a small ring enhancing or a small homogenously 
enhancing lesion (radiologically termed 'granuloma') with surrounding white matter oedema 
(Minguetti and Ferrreira 1983; Mazer et al 1983; Carbajal and Duran 1983; Sotelo 1987) 
(Radiology 6). These CT scan features have been correlated with the histologic findings of the 
encysted parasite surrounded by inflammatory exudate and oedema (Madrazo et al 1983; Rangel 
et al 1987). These 'granulomatous' encephalitic lesions may vary in number from a single lesion 
to many lesions, the term miliary being used to describe the latter (Sotelo et al 1985) . Prior to 
the use of CT scanning only the severe miliary forms were occasionally diagnosed antemortem in 
endemic areas . Ventriculography done in these patients demonstrated symmetrically swollen 
brains with slit ventricles and effacement of the cortical sulcal pattern (Stepien 1962). 
Using these radiologic criteria 11 6 patients (80 children, 36 adults) were identified as presenting 
the features of cysticercal encephalitis . Sixty six patients had five or less enhancing lesions on 
their presenting CT scans. For the purposes of this study these patients were defined as having 
focal encephalitis (Table 2). 
TABLE 2: FOCAL CYSTICERCAL ENCEPHALITIS 
CT scan findings: 
Granulomas with oedema (34 child, 27 adult) 
Enhancing cysts with oedema (0 child, 5 adult) 
Clinical features : 
Epilepsy alone (28 child, 25 adult) 
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Epilepsy + mass effect + t ICP (0 child, 3 adult) 
66 patients 
= 61 patients 
= 5 patients 
= 53 patients 
= 1 0 patients 
= 3 patients 
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Radiology 7 
CT scan (with contrast) damonstrating a single 
enhancing lesion with oedema of the surrounding 
white matter - focal cysticercal encephalitis 
in the right frontal region . Note the cystic 
lesion with a calcific scolex present in the 
right parietal region as well as the calcific 
speck in the left parietal region. 
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Of these 66 patients with focal encephalitis 33 had single enhancing lesions with associated 
oedema on their CT scans (Radiology 7). These 33 patients were clinically accepted as having 
neurocysticercosis for the following reasons. Twenty of the 33 had in addition to the single 
enhancing lesions multiple intra-cranial calcific foci on their CT scans ( 1 adult patient had in 
addition multiple non-enhancing cysts). Two the 33, both adults, had their cystic lesions 
biopsied with positive histologic confirmation of cysticercosis. Three of the 33 demonstrated an 
increase in the number of enhancing lesions following on Praziquantel therapy before these 
lesions all resolved over the subsequent few months. Four of the 33 had positive cysticercus 
antibody titres in blood and/or CSF (serological testing had only been undertaken in 16 of the 33 
patients and was positive in 8 of them). The remaining 4 patients had single lesions which 
resolved over a period of a few months. No specific therapy was given to 2 of these patients 
while the remaining 2 had received a course of Praziquantel. 
Fifty patients of the 116 patients with encephalitis presented with the syndrome of Multifocal 
Cysticercal Encephalitis. The CT scan of the brain of these patients demonstrated the presence 
of diffuse or extensive multifocal cerebral oedema and in addition the presence of multiple 
enhancing lesions well in excess of 6 and often innumerable. 
TABLE 3 : MULTIFOCAL CYSTICERCAL ENCEPHALITIS 
Radiologic findings: 
Granulomas with oedema (CT) (42 child, 2 adult) 
Enhancing cysts + oedema (CT) (0 child, 4 adult) 
Swollen brain (vent) (2 child, 0 adult) 
50 patients 
= 44 patients 
= 4 patients 
= 2 patients 
These fifty patients (20.9% of the total series) with the clinical features of generalized 
encephalopathy and radiologic features of acute multifocal cysticercal encephalitis form the study 
group for further analysis. These patients would have been classified as Group II classification of 
Stepein et al, Group Ille classification of Rodriguez-Carbajal et al, Group IB and IC classification of 
Sotelo et al and Category I classification of Stern. 
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RESULTS 
Forty-four of these 50 patients were children ( < 12 years). In the total group of 123 children 
35. 7% were diagnosed as having Multifocal Cysticercal Encephalitis (Graph 7 - Age distribution). 
The ages of the 6 patients in the adult group ( > 12 years) were 13, 16, 20, 22, 25 and 27 
years, that is all young adults with two of them belonging to the teenage group of 14 patients. 
Amongst the children 26 patients were female and 18 were male, and amongst the adults 4 were 
male and 2 were female. Forty-eight of the patients were Xhosa, 1 white male from the South 
Cape (Oudtshoorn), and 1 coloured male from the North West Cape (Wuppertal). 
CLINICAL FEATURES 
As the adult group consisted of so few patients the clinical features of the whole group were 
analyzed together. The initial symptoms of the illness were convulsions in 27 cases (54.0%), 
headache with or without vomiting in 18 cases (36%), behaviour and cognitive disorder in 3 
cases (6%) and myalgia with fever in 2 cases (4%). As the last 2 patients were more 
sophisticated and thus able to give more detailed histories perhaps the symptoms of myalgia and 
fever were more common than the available histories suggest. There was a wide range in the 
duration of illness prior to admission but from the available histories it was not often clear as to 
when the more dramatic illness began. This duration of illness varied from < 1 /52 in 10 patients 
(20%) to < 1/12 in 11 patients (22%) to < 3/12 in 9 patients (18%) and to < 6/12 in 11 
patients (22%) Nine patients (18%) were symptomatic for longer than 6/12. 
Symptoms and signs on admission are presented in Table 4. 
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TABLE 4: CLINICAL FEATURES MULTIFOCAL CYSTICERCAL ENCEPHALITIS 
PRESENTING SYMPTOMS - 50 patients 
1. 
2. 
3. 
4. 
Convulsions 
(Epilepsy 
(Acute seizures 
Status epilepticus 
Headache and vomiting 
Myalgia and fever 
Behaviour and Cognitive Disorders 
FINDINGS ON ADMISSION - 50 patients 
1 . Papilloedema 
2. Acute confusion /delirium 
3. Depressed level of consciousness 
4. Focal neurological signs 
5. Meningeal Signs 
44 cases 
(22 cases 
(22 cases 
16 cases 
39 cases 
11 cases 
9 cases 
23 cases 
19 cases 
19 cases 
18 cases 
8 cases 
88% 
(44% 
(44% 
32% 
78% 
22% 
18% 
46% 
38% 
38% 
36% 
16% 
The commonest presenting symptom was convulsions in 44 patients (i.e. 22 epileptic and 22 
patients with acute seizures). Acute seizures were definied as seizures with initial onset 
occurring within the week prior to admission. Amongst the 44 patients who presented with 
convulsions, 22 had focal onset seizures with secondary generalisation more often than they had 
seizures with a generalised onset, 15 had generalized tonic/clonic seizures only, 4 had complex 
partial seizures with secondary generalization and 3 had focal seizures only. 
Headache with or without vomiting was the next most common symptom occurring in 39 cases 
(78%). Papilloedema was found in 23 (12 males and 11 females) of these patients with raised 
intra- cranial pressure. Papilloedema has been recorded as the commonest neuro-ophthalmologic 
sign in neurocysticercosis (Keane 1982). Depressed level of consciousness was found in 19 
patients ( 11 males, 8 females) and the combination of depressed level of consciousness and 
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papilloedma was found in 11 patients (5 males, 6 females). Thus 8 patients (6 males, 2 females) 
had depressed level of consciousness without papilloedema. In three of these patients associated 
status epilepticus was noted on admission and was no doubt a contributing factor to the 
depression of consciousness. 
Eighteen of the patients had focal neurologic signs. Most of these were the result of the 
markedly increased intra-cranial pressure. Except in 2 patients (1 with optic atrophy and 1 with 
quadriplegia) all of these signs resolved on reduction of the intra-cranial pressure. Fourteen were 
ataxic (12 with gait ataxia, 1 with truncal ataxia and 1 with limb ataxia). In addition 2 of these 
patients had nystagmus. Excluding the patients with papilloedema, 10 in addition to the 2 with 
nystagmus had cranial nerve involvement (1 with optic atrophy, 5 with non-localizing 6th nerve 
palsies, 3 with upward gaze palsies, 1 with pseudobulbar palsy). Following on papilloedema with 
or without abducens palsies, prectectal findings of upward gaze palsy and pupillary abnormalities 
have been reported to be the second major group of neuro-ophthalmological signs in 
neurocysticercosis (Keane 1982; Keane 1990). Motor weakness was found in two patients with 
hemiplegia and 1 with quadriplegia and dystonia (the patient with pseudobulbar palsy). One 
patient had cortical blindness. The patient with optic atrophy, an adolescent female, had the disc 
features diagnostic of long-standing raised intra-cranial pressure and not those of perichiasmatic 
compressive arachnoiditis. 
LABORATORY INVESTIGATIONS 
Laboratory investigations were also analyzed for the group as a whole. 
Cerebro-spinal fluid findings: Forty-seven patients were lumbar punctured. In 30 of these 
patients, with clinical features suggestive of raised intra-cranial pressure, lumbar puncture was 
performed only after CT scans of the brain had been done and the raised intra-cranial pressure 
lowered by means of Dexamethasone therapy ( + Mannitol in 5 cases). Effective reduction of 
intra-cranial pressure was equated with the improved level of consciousness of the patient. In 20 
patients the pressure of the cerebrospinal fluid was measured and in 14 was found to be elevated 
above 18 cm of water confirming the presence of raised ICP in those 14 patients. Four of these 
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14 patients had completely normal CSF on chemical and cellular analysis. In 32 of the 4 7 
patients lumbar punctured analysis of the CSF was found to be abnormal. In 2 of the adult 
patients the abnormality may have been related to the presumed presence of other CNS 
infections. Therefore these two CSF's have been excluded from the analysis. 
TABLE 5: CSF FINDINGS IN 45 CASES OF MUL TIFOCAL CYSTICERCAL ENCEPHALITIS 
CSF Normal = 15; Abnormal = 30 = 45 
Globulin Negative = 23; Positive = 22 = 45 
Protein < 0.5 g% = 33; 0.5-1.0 g% = 7; > 1.0 g% = 5 = 45 
Glucose <3g% = 10; >3g% = 35 = 45 
Lymphs 0-5 = 15; 5-50 = 23; 50-100 = 5 = 45 
> 100 = 2 
Polys 0 = 28; 1-50 = 13; 50-100 = 2 = 45 
> 100 = 2 
Eosinophils Not done = 28; Positive = 6; Negative = 11 = 45 
Comparative blood glucoses were not obtained at the time of lumbar puncture. To detect 
eosinophils in the CSF special staining techniques are required and were only requested or done 
in 17 of the CSFs analysed. Bacterial culture, TB culture and cryptococcal antigen were negative 
in all 30 abnormal CSFs. 
Cysticercus antibody tests: Serologic testing for the presence of cysticercus antibodies was 
carried out in the sera of 40 patients and in the CSF of 37 patients. These tests were carried out 
at the Research Institute for Diseases in a Tropical Environment of the South African Medical 
Research Council, Durban. Initially an indirect haemagglutination (IHA) test was utilized but 
subsequent to 1 983 this was replaced by the more specific enzyme-linked immunosorbent assay 
(ELISA) test (Pammenter et al 1987). None of these patients had sera nor CSF tested by the 
more recent combination of ELISA and immunoblotting which has proved to be highly sensitive 
and more specific than the ELISA alone in the immunodiagnosis of neurocysticercosis (Gottstein 
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TABLE 6: IHA AND ELISA TESTS 
MUL TIFOCAL CYSTICERCAL ENCEPHALITIS - 44 CHILDREN 
BLOOD 0 + ++ +++ 
CSF 0 3 4 2 = 9 
1 1 2 = 4 
+ 2 2 1 = 5 
++ 1 2 6 = 9 
+++ 2 1 14 = 17 
= 44 
Blood 0 CSF 0 = 3 
Blood 0 CSF = 1 
Blood 0 CSF + = 2 
Blood CSF = 1 
Blood CSF + = 1 
Blood + CSF 0 = 6 
Blood + CSF = 2 
Blood + CSF + = 28 
44 
Key: 
0 = Not done 
= Negative 
+ = Slightly positive 
++ = Moderately positive 
+++ = Strongly positive 
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et al 1987; Shasha and Pammenter 1989). 
However, as the CT scan findings in these patients were completely unlike the CT scan findings 
that would be expected in children with cerebral echinococcus (hydatid disease), the problem of 
possible cross-reactivity of the cysticercus ELISA test with hydatid antigen does not arise and 
does influence the diagnosis of these cases (Ozgen et al 1979). Thirty-seven of 40 patients 
whose sera were tested were found to contain cysticercal antibodies. Thirty-one of 37 patients 
whose CSF were tested were found to contain cysticercal antibodies. 
From Table 6 which documents the results of the immunological tests (IHA and ELISA) done in 
the blood and CSF of the children, it can be seen that both the blood and CSF of 32 children was 
tested. Twenty-eight children were positive in both blood and CSF, 2 children were positive in 
blood and negative in CSF, 1 child was positive in CSF but negative in blood and 1 child was 
negative in both blood and CSF. Six children who only had blood tested were positive, 3 who 
only had CSF tested were positive in 2 and negative in 1 and the 3 remaining children had neither 
blood nor CSF tested. Amongst the 6 adult patients only 3 were tested. One was negative in 
both blood and CSF, one was positive in blood (CSF not checked), and 1 was negative in CSF 
(blood not checked). 
Haematologic investigations revealed that 4 patients had haemoglobin levels below 11 g% (all 
children). Only 1 of these had an MCV below 72 but milder degrees of iron deficiency may have 
existed partly explaining the platelet counts in excess of 400 000 in 29 patients. However, the 
most likely explanation for these high platelet counts is the presence of infection. White blood 
cell counts in excess of 12 000 cells with polymorphs exceeding 70% of the differential count 
were found in 12 patients. Only 14 patients demonstrated an eosinophilia in excess of 5% on 
differential count. Erythrocyte sedimentation rate was elevated above 20 mm Westergren in 29 
patients and above 50 in 11 of these patients. 
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Radiology 8 
X-ray of a child's scull demonstrating marked sutural 
diastasis due to raised intra-cranial pressure 
Radiology 9 
Skull X-ray demonstrating the presence 
of numerous intra-cranial calcific foci. 
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Biochemical investigations: There were no abnormalities in hepatic or renal function tests in any 
of the patients. Calcium and glucose metabolism were also normal. 
Radiologic findings: In 17 patients radiology of soft tissues (X-ray thighs) was performed and in 
2 of these patients, both adults, calcific lesions were visible in the muscles and or subcutaneous 
tissues. X-rays of the skull were reviewed in 48 patients as there was no trace of skull X-rays in 
2 of the patients. In 17 patients the skull X-ray was normal. Among the 31 patients with 
abnormal skull X- rays, 28 showed evidence of raised intra-cranial pressure (24 with diastasis of 
skull sutures, 1 with diastasis and intra-cranial calcific foci, 2 with erosion of posterior clinoids, 1 
with erosion of posterior clinoids and intra- cranial calcification) (Radiology 8). The skull X-rays 
of the 3 remaining patients demonstrated intra-cranial calcific foci only (Radiology 9). 
Using high resolution CT scanners (Elscint 905 and 1800) CT scans of the brain were done in 48 
of these 50 patients initially. Two patients were diagnosed prior to the availability of scanning at 
Groote Schuur Hospital and only 1 of these was subsequently scanned at the 1 year follow-up. 
On admission forty scans were done with and without contrast, 6 with contrast only and 2 
without contrast only. Among the 48 abnormal scans 11 demonstrated generalized oedema with 
compressed ventricular system (Radiology 10), 29 demonstrated generalised oedema with 
compressed ventricular system and multiple ring enhancing lesions following contrast 
administration (Radiology 11), 5 demonstrated multifocal oedema with multiple enhancing lesions 
following contrast administration, and 3 demonstrated multifocal oedema with multiple cystic 
lesions which enhanced following contrast administration (Radiology 12). The CT scans of 13 of 
these patients demonstrated the presence of calcific foci as well. Magnetic Resonance Imaging 
was performed in 2 patients and was abnormal confirming the CT scan findings . 
Ventriculography was performed in 2 patients prior to the availability of CT scan facilities at GSH . 
Both were performed with some difficulty revealing extensive brain swelling with compressed 
ventricles . 
Electroencephalography was done in 39 patients and was found to be abnormal in 34. Thirty-one 
of these patients had EEG's with generalized slowing and 3 had EEG's with focal slowing and 
focal spikes. 
Radiology 1 1 _. 
CT scan (with contrast) demonstrating generalised 
oedema and ring enhancing lesions in the same 
patient on steroid therapy 1 month later. 
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~ Radiology 10 
CT scan (with contrast) demonstrating generalised 
oedema in a child with multifocal cysticeral 
encephalitis and severe raised intra-cranial pressure . 
~ Radiology 12 
CT scan (with contrast) in an adolescent patient 
demonstrating enhancing cysts wi th varying degrees 
of multifocal oedema. 
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DISCUSSION 
The earliest reference to patients with multifocal parenchymal neurocysticercosis was from 
Poland (Stepien and Chorobski 1949). These patients presented with features of raised 
intracranial pressure and at ventriculography were found to have symmetrically swollen brains. 
Some of these patients came to autopsy and were noted to have diffuse or extensive multifocal 
oedema in relation to the many intracerebral parasites. Further experience was published from 
the same medical centres (Stepien 1962). Subsequent reports relating to neurocysticercosis prior 
the the advent of CT scanning did on occasion make reference to cerebral oedema complicating 
multifocal parenchymal neurocysticercosis. These reports emanated from Rumania (Arseni and 
Samietea 1957), India (Balasubramaniam et al 1971; Vinayan et al 1977) and Mexico (Cardenas 
1962; Gani 1962). 
Two such children from the present series presented with clinical features of raised intracranial 
pressure and were found to have diffuse cerebral swelling on ventriculography. Subsequent 
studies confirmed the diagnosis of multifocal parenchymal neurocysticercosis. The clinical and 
radiologic findings of these two patients have been reported previously (Thomson 1984; Handler 
1983). With hindsight, it is reasonable to presume that in the pre-CT scan era, children from 
endemic areas with the syndrome of Diffuse Encephalopathy due to multiple parenchymal 
neurocysticercosis were often misdiagnosed. They were probably diagnosed as cases of either 
'toxic' /'metabolic' encephalopathy or viral para/post-infectious encephalitis or even in the milder 
cases as benign intracranial hypertension. 
With the widespread use of CT scanning in endemic regions a flurry of papers reporting and 
highlighting this multifocal parenchymal form of neurocysticercosis have appeared from Latin 
America (Minguetti and Ferreira 1983; Maser et al 1983; Rodriquez-Carbajal et al 1987; Carbajal 
et al 19831, India (Wadia et al 1988), and South Africa (Thomson et al 1984; Handler and Mervis 
1983). With few exceptions most of the patients reported in these 2 South African papers were 
referred from the Eastern Cape territories of the Ciskei and the Transkei both known as highly 
endemic regions. 
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Forty four of the 50 patients with multifocal cysticercal encephalitis were children 1 2 years of 
age or younger. Of the remaining 6 patients 2 were adolescents and 4 adults who were all in the 
3rd decade. Thus only 4 of 102 adult patients (3.9%) had multifocal cysticercal encephalitis 
whereas 2 of 14 adolescents (14.3%) and 44 of 123 children (35.7%) of 12 years or younger 
were so diagnosed. These figures certainly confirm previous reports that multifocal cysticercal 
encephalitis is much more common in children referred to hospital (Stepien 1 962; 
Balasubramaniam et al 1971; Hernandez and Caraizar 1982a&b). The reported incidence of this 
form of neurocysticercosis in childhood varies quite widely and is dependent on the nature of the 
centre reporting the patients. Most of the patients in this series were referred from 
secondary/tertiary care hospitals for diagnosis and evaluation. Thus by no means do these 
figures reflect the incidence or prevalence of multifocal cysticercal encephalitis in the total 
paediatric cysticercosis population of the Eastern Cape. Many children infested with the 
cysticercal parasite may remain asymptomatic or may be only mildly and transiently ill and 
therefore do not present to hospital. Other children may present to hospital with the problem of 
seizures which if easily controlled are not referred for further investigation. 
Although the distribution of acute multifocal cysticercal encephalitis was slightly more common in 
the female in this series (28 females to 22 males) there was no significant sex difference 
amongst the severely ill patients. Females did not comprise the majority of those who were very 
ill (13 females to 19 male). These findings are at variance with some previously reported series 
(Rangel 1987; Del Brutto et al 1988). 
In this series the duration of illness prior to admission with the more florid signs of 
encephalopathy was extremely varied. Correlation of the duration of the preceding illness with 
the initial symptomatology and admission CT scan findings was not possible. However, it was 
obvious that the 3 patients with histories longer than 6/12 and the 6 patients with histories 
longer than 12/12 presented with epilepsy as the main problem until episodes of raised 
intracranial pressure precipitated admission. Of interest only 4 of their 9 CT scans manifested 
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calcific foci in addition to the findings of multifocal cysticercal encephalitis ( 1 with a history of > 
6/12 and 3 with histories of > 12/12). Thus 5 patients with long histories had no evidence of 
intra-cranial calcification on their CT scans. 
Twenty CT scans were performed on the 21 patients who presented with relatively brief 
preceding illnesses (1 O < 1 /52, 11 < 1 /12) manifesting with headache with or without vomiting 
and with recent onset of seizures (6 with status epilepticus). Five of these scans showed calcific 
foci in addition to cysticercal encephalitis. The other one of these 21 patients only had 
ventriculography performed which demonstrated marked bilateral cerebral swelling. 
The 20 patients with histories longer than 1 /1 2 but less than 6/1 2 presented with epilepsy and/or 
fluctuating episodes of headache and vomiting. Three of these patients were, in addition, 
reported to have shown a marked decline in cognitive function. As 1 patient, prior to availability 
of CT scanning, had ventriculography which demonstrated bilateral cerebral swelling, only 19 
scans were done. In 3 of these scans calcific foci were seen in addition to the usual features of 
cysticeral encephalitis. 
Thus 12 patients in this group of multifocal cysticercal encephalitis had evidence on CT scan of 
calcific foci. Five of these CT scans were found in patients with brief preceding histories 
suggesting previous asymptomatic disease in these patients and only 4 CT scans of 9 patients 
with lengthy histories had calcific foci suggesting that the evolution of the disease process varies 
widely in different patients and possibly may not always terminate in calcification (Miller et al 
1983). 
Although 11 (22%) of these patients were recorded as having myalgia and high fevers during 
their initial admission only 2 (4%) admitted to myalgia and fever as their initial symptom. One of 
the patients had a very observant trained nursing sister for a mother and the second patient was 
a sophisticated teenager. Of interest, both these patients were initially considered to have 
rheumatic fever by the referring doctors. It is very likely that as most of these patients came 
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from unsophisticated families of poor socio economic standing the symptoms of myalgia and 
fever were considered minor and not reported or forgotten in relation to the seriousness of the 
other more dramatic symptoms. 
One of the adult patients was, on examination, found to have 3 sub-cutaneous nodules. Excision 
biopsy of one of these was performed. Histological examination confirmed the presence of 
cysticercus cellulosae. In the experience gained from this series the presence of sub-cutaneous 
nodules was extremely uncommon, unlike the findings from other series (MacArthur 1934). 
Perhaps the clinical search required to establish their presence was not diligent enough. We 
certainly have not seen patients with the pseudohypertrophy of muscle as reported in series from 
India (Sawhney et al 1976; Venkataraman et al 1982; Wadia et al 1988). 
The clinical picture of multifocal cysticercal encephalitis has been well described and although not 
diagnostic is sufficiently characteristic to suggest the diagnosis in patients from endemic areas 
(Rangel et al 1987; Hernandez and Garaizar 1982a). These 50 patients clearly comply with this 
clinical picture except for the previously noted female predominance (Rangel et al 1987; Del 
Brutto et al 1 988). The patient is almost always a child or occasionally an adolescent or rarely 
even a young adult. However, a report from mainland China describes 33 patients aged from 13 
- 55 years with intra-cranial hypertension due to cerebral cysticercosis. Twenty one of these 
patients had general or focal oedema with 'allergic' changes in the CSF. It seems that 4 had 
diffuse oedema and 8 had multiple 'nodules' but unfortunately the ages of the patients are not 
given (Feng 1987). The symptoms are dominated by seizures (not infrequently by status 
epilepticus) which are commonly associated with complaints of headache and vomiting. The 
more ill the patient the more florid are the manifestations of raised intracranial pressure with 
findings such as papilloedema and depressed levels of consciousness. In a few patients the 
development of cerebral oedema and the resultant increase in intracranial pressure was so 
dramatic that depressed levels of consciousness without the development of papilloedema were 
produced. This circumstance occurred in 5 of these 50 patients. However, it is more usual for 
the cerebral oedema to develop more slowly with the associated development of papilloedema. 
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Associated features such as fever, myalgia and meningeal irritation tend to be less prominent and 
are therefore eclipsed by the dramatic features of seizures and raised intracranial pressure. That 
only 9 of the 50 patients presented with a history of behaviour or cognitive disorder is of 
interest. This finding may reflect either inadequate history taking due to language difficulties or 
may reflect that almost all of these patients came from unsophisticated rural communities and 
therefore these more subtle signs were possibly not observed. However 19 (38%) of these 
patients were noted to have an apparently obvious confusional state on admission with bizarre 
behaviour and occasional hallucinations. As mentioned previously it is apparent from the 
histories of some of these patients that the bouts of encephalopathy may fluctuate and vary in 
intensity over some months. 
Of the 45 patients lumbar punctured, 1 5 patients had completely normal cerebrospinal fluid 
findings confirming that at least in one third of these patients there was no florid meningeal 
involvement and that 'all' of the detectable host parasite interaction was intraparenchymal and 
indeed 'purely' encephalitic. However, 30 patients had abnormal CSF's associated with their 
florid encephalitic picture suggesting that in the majority (two thirds) a meningo-encephalitis is 
present. The commonest abnormal finding in the CSF was the presence of cells, a pleocytosis in 
17 cases and a pure lymphocytosis in 13 cases. The CSF globulin was abnormal in 22 cases 
although the total protein was only elevated in 1 2. CSF glucose was reduced below normal in 10 
cases - unfortunately concomitant blood glucoses were not obtained. The presence of CSF 
eosinophilia is stated to be a common finding in neurocysticercosis (Arseni and Cristesau 1972; 
Goni 1962). However the finding of only 6 positives amongst the 17 cases, who had special 
staining of the CSF sediment for eosinophils, does not confirm this statement but rather supports 
the opposite finding of others (Vinayan et al 1977; Miller et al 1983). The CSF abnormalities in 
the cases of cysticercal meningoencephalitis are most commonly those of an aseptic meningitis 
although very occasionally the changes of a bacterial meningitis may be mimicked (Loo and 
Braude 1982; Miller et al 1983). 
The high rate of positive serology in this group of patients with multifocal cysticercal encephalitis 
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with or without overt meningitis is to be expected and has been reported (Miller et al 1983; Miller 
et al 1983; McCormick et al 1982; Sotelo 1985a). However, this has not been the finding in all 
reports (Rangel et al 1 987). Both blood and CSF were tested simultaneously for antibodies to 
cysticercal antigen in 33 patients. Twenty eight of these patients demonstrated positive titres in 
both blood and CSF, 2 positive titres in blood only, 1 positive titre in CSF only while 2 patients 
had neither antibodies in blood nor CSF. Seven further patients who had only blood serology 
done were positive as were 2 of 4 patients who only had CSF testing done. Thus 37 of 40 sera 
tested were positive and 31 of 37 CSF's tested were positive, suggesting that a significant 
response to cysticercal antigens occurs in this form of neurosysticercosis and the titre of 
antibody may correlate to the degree of inflammatory response present. Although intra-blood-
brain barrier lgG synthesis occurs in neurocysticercosis (Miller et al 1985) and although it has 
been suggested that the CSF antibody titres are more likely to be positive than the blood titres 
(Sotelo 1988; Miller et al 1983; Rosas et al 1986) this has not been confirmed in this series. 
Presumably this is because of the system then in use at the Research Institute for Disease in a 
Tropical Environment of the South African Medical Reserarch Council, Durban (Pammenter et al 
1 987). Of interest, 6 of the CSF' s which had positive titres of cysticercal antibodies were 
completely normal on routine examination whereas only 1 CSF documented with pleocytosis had 
negative antibody titres. In a recent report high cysticercus antibody levels in blood and CSF of 
patients correlated well with those who had active malignant disease i.e. multiple granulomata, 
hydrocephalus, vasculitis and cerebral infarction (Zini et al 1990). 
The radiologic findings were indeed interesting. Only 2 of 17 patients in this group had evidence 
of extracranial calcification on radiology of the soft tissues. The paucity of this radiologic finding 
was also noted in the other clinical groupings of this series. Both of these patients were adults. 
The skull x-ray was found to be a useful examinaton as features of raised intracranial pressure 
such as sutural diastasis or erosion of the posterior clinoids were found in 28 of these patients. 
Two of these 28 skull X-rays also showed evidence of intracranial calcification. A further 3 of 
the patients' skull X-rays showed intra-cranial calcification as the only abnormality. 
48 
Radiology 13 
Serial CT scans of a young child with an extensive right cerebral 
infarct and intractable epilepsy. These scans spanned a one year 
period and did not demonstrate the presence of multifocal neurocysti-
carcosis which was found at hemispherectomy. 
(see Figures 3 and ,4). 
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It was of interest to note that the CT scan appearances of 4 of the adult/adolescent group 
differed from those of the paediatric patients. These 4 CT scans, besides the features of 
oedema, demonstrated the presence of well demarcated enhancing cysts. However, none of the 
paediatric patients with cysticercal encephalitis, had well demarcated cystic lesions on their 
scans. These paediatric CT scans demonstrated ring enhancing or miliary enhancing lesions in 
addition to the extensive oedema. In fact 10 of the children's CT scans only showed extensive 
oedema initially and follow-up in 5 showed the development of ring enhancing lesions at 1-2 
months in 4 and at 3-4 months in the 5th. This difference between the CT scan findings in 
children and adults with multi-focal disease has been commented on previously (Mitchell and 
Crawford 1988). However, in an earlier report from the same centre in Los Angeles 3 children 
less than 12 years of age are listed as having focal cystic lesions (Mitchell and Snodgrass 1985). 
In our experience with children, who present with multifocal or paucifocal cysticercal 
encephalitis, the parasitic cyst prior to the encephalitic phase has not yet evolved into a size large 
enough to be detected by CT scanning. It seems that it is only when the pericyst blood-brain 
barrier breakdown occurs with the resultant host inflammatory reaction that the parasite becomes 
detectable in the patches of oedema as a ring enhancing and later as a miliary enhancing lesion. 
Pathological correlation with MRI findings has suggested that the parasitic cysts which are viable 
with intact scoleces and cyst walls are too small to be detected by CT scanning or even by 
present MRI (Lotz et al 1988). Our experience with a 2 year old child confirms this finding. She 
presented with acute hemiplegia due to a large infarct in the territory of the right middle cerebral 
artery and later developed severe intractable epilepsy. Three CT scans done over a 12 month 
follow-up period failed to demonstrate the numerous cysticerci found in both the infarcted and 
non-infarcted hemispheres at right hemispherectomy which was done for the intractible epilepsy 
in this patient (Radiology 13) (Figures 3 and 4). 
The CT scan finding of 'parenchymal' cystic lesions in children resembling those usually found in 
adults or less commonly in adolescence has been reported (Hernandez et al 1 982a; Byrd et al 
1982). However, it is not clear from either of these reports whether the few patients with cystic 
lesions were adolescents or were indeed pre-adolescent children. Although there are case reports 
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of symptomatic children with intra-ventricular cysts and we have treated one such child, this 
must be a very rare occurrence (Tasker et al 1979; Woody et al 1984). It would seem to be as 
rare for children under the age of 12 years to become symptomatic with viable chronic cysts 
involving the brain parenchyma. In an excellent paper correlating serial CT scan findings of the 
brain in patients with neurocysticercosis an attempt was made to document the natural history of 
parenchymal cerebral cysticercosis (Kramer et al 1989). Of interest these authors correlated the 
presence of visible non-enchancing cysts (chronic cysts) on CT scan with cysts containing viable 
invaginated larvae bathed in clear fluid as determined by pathological examination. This finding is 
at variance with that of a recent MRI correlative anatomo-pathological study where the enlarging 
cysts visible on MRI although consisting of viable capsules had either hyalinised or calcified 
scoleces on histological examination (Lotz et al 1 988). It appears therefore that for cysts 
(cellulosae or racemosae) to enlarge the cyst capsule must continue to function in order to evade 
the hosts immune surveillance. However, the scoleces in these enlargings cysts are no longer 
viable being either hyalinised, calcified or even resorbed. 
Many facets of the evolution of the parasitic larval phase in the host are not understood. What 
are the mechanisms that allow the parasite to evade the host defence system and consequently 
to enlarge for perhaps 30 years or more forming massive giant cysts? The finding of giant cysts 
has been reported previously (Berman et al 1981; Joubert and Van As 1990) (Radiology 5). Why 
at the opposite end of the spectrum do some larvae invoke a severe host inflammatory response 
probably within a year or two of infestation while the cystic lesions are still at a stage too small 
to be detected by present imaging methods? 
Parasites are obviously able to evade the hosts immune system. Some of these mechanisms are 
known and others are presumed. Parasites such as trypanosomes and plasmodium are able to 
vary their surface antigens and thereby form a changing buffer coat around the organism thus 
preventing lysis of the parasite by host antibodies. Schistosomela can acquire immunity to the 
host by appropriating host molecules including histocompatibility antigens onto their surface layer 
and thus can mimic the antigenic structure of the host and remain undetected by the host's 
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immune surveillance system. Trypanosomes and Leishmania can learn to live with macrophages 
by not fusing with macrophage lysosomes, by evolving resistance to the specific selected host 
macrophage and by escaping from macrophage lysosomes and residing in the cytoplasm of the 
macrophage. Plasmodium, Leishmania and Trypanosomes are known to suppress the immune 
response directly by causing non-specific polyclonal response of 8-lymphocytes and possibly a 
suppression of T-cells as well (Bloom 1979; Nussenzweig 1982). That some of the above 
mechanisms are available to the cysticercus are supported by the absence of demonstrable 
antibodies in many cases of neurocysticercosis (Rosas 1986; Flisser et al 1980). It has been 
suggested that the larvae may survive for long periods in the brain because the brain provides an 
environment which is relatively protected from the immune response (Miller 1983). This long 
survival of the cysticercus occurs mainly in the larger subarachnoid spaces as well as the 
ventricular system and appears to depend on the viability of the cyst wall and not the viability of 
the scolex which is either hyalinsed, calcified or destroyed and absent in these larger cellulosae or 
racemose cysts. 
However, in some patients particularly in children with 'parenchymal' disease a massive 
inflammatory reaction is mounted against the parasitic cyst despite the parasites inheritant ability 
to evade immune detection. This reaction manifests with inflammatory cell infiltration and 
vasculitis in the pericystic tissue. An extensive oedema of the brain parenchyma and a meningitic 
response manifesting in the cerebra-spinal fluid as a pleocytosis results. It has been postulated 
that the eventual death of the larvae after about 2 years in the more confined spaces of the 
cortical sulci and parenchyma of the host's brain results in a leak of parasitic antigens and 
promotes a massive antibody response on the part of the host i.e. that the death of the parasite 
sparks off the inflammatory response. Destruction of the parasite by the use of parasitocidal 
drugs has been reported to cause a similar inflammatory response and a marked rise in the 
antibody titres of the host (Miller 1983). 
An interesting report from Mexico draws attention to a number of autopsies performed in children 
with neurocysticercosis (Sanz 1987). The children who were presumed to be immunologically 
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normal demonstrated evidence of cysticercal encephalitis whereas children who died due to the 
effects of malignant disease or who were markedly immnosuppressed for other reasons 
evidenced viable cysticerci with no inflammatory response in their brains. These findings may 
lend support to the suggestion that the hosts immune system in some way is activated 
sufficiently to bring about the initial damage to the parasitic capsule thus destroying the parasites 
ability to evade immune detection (Rabiela-Cervantes et al 1 982). 
The cases with multifocal or diffuse cysticercal encephalitis in this series, had without exception, 
many parasitic lesions in the brain. An autopsy was done in one patient who had been treated 
with Praziquantel and who died of disseminated chicken pox due to prolonged steroid immune 
suppression. Examination of the brain showed that the many degenerated cysts with pericyst 
inflammatory cells, vasculitis and oedema were in the cortical mantle or related subarachnoid 
spaces of the deeper cortical sulci. Most reports in the literature correlate extensive or 
multifocal oedema with numerous parasitic lesions (Minguetti and Ferreira 1983; Mazer et al 
1983; Handler and Mervis 1983; Rangel et al 1987; Hernandez and Garaizar 1982a&b). 
However, one report from India described patients with diffuse cerebral oedema related to single 
viable or non-viable parasitic cysts and suggested that some form of massive allergic response to 
the parasitic antigen was the cause of the fatal cerebral swelling (Srinivas et al 1980). Although, 
for their stated reasons, an associated viral encephalitis in an endemic cysticercotic region was 
felt to be unlikely, this probability cannot be excluded. Amongst the patients seen at Groote 
Schuur Hospital those children with focal degenerating parasites manifested only focal oedema 
and no cases as described in the above report were seen. 
Some points of interest relating to these patients with extensive multifocal cysticercal 
encephalitis are unfortunately not available for discussion. Firstly, the history of pica was not 
specifically elicited and was recorded only in the occasional case report. Therefore, no comment 
can be made about the possible link between pica and an increased risk of extensive multifocal 
neurocysticercosis. Secondly, only very occasional stools from these patients were examined for 
the ova of Taenia solium so again no comment can be made about the possible risk of heavy 
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infestation in patients harbouring the adult worm. Reports documenting the presence of Taenia 
solium ova in the stools of patients with all forms of neurocysticercosis conclude that a minority 
of about 25% of the patients have the adult worm in their bowel (Loo and Braude 1982; Arseni 
and Samitca 1957; Dixon and Hargreaves 1944; Heinz and Klintworth 1965; Stepien 1962; Bia 
and Barry 1986). However, a report from Brazil noted that all but one of 19 patients with acute 
multifocal enhancing lesions and oedema on CT scan had the ova of Taenia solium in their stools 
(Minguetti and Ferreira 1983). This finding suggests that auto inoculation (i.e. anus to mouth or 
even possibly retrograde peristalsis) may be the cause of such extensive infestation. 
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PART IV 
MUL TIFOCAL CYSTICERCAL ENCEPHALITIS - FOLLOW-UP 
INTRODUCTION 
Follow-up of all 50 patients with multifocal cysticercal encephalitis was only possible for the first 
4 weeks following on their presentation. Twenty one patients had been treated symptomatically 
and their case records were all reviewed retrospectively. Twenty nine patients had formed part 
of a prospective open therapeutic study using Praziquantel in addition to supportive therapy. 
However, beyond the first month comparison of the outcome of the 2 groups is impossible as the 
numbers, especially amongst the retrospective group, are too few for any valid conclusions. 
However, as the follow-up notes in some of the case reports were extensive and available the 
findings were considered worth reporting. A few personal observations regarding the outcome of 
the 2 groups will be made but it is important to note that no valid conclusions regarding the 
effect of Praziquantel on the outcome or 'natural history' of this form of neurocysticercosis can 
be reached. 
METHODS 
For this part of the study the outcome of these 50 patients with multifocal cysticercal 
encephalitis were reviewed where it was possible. Twenty-one (19 children, 2 adults) of the 50 
patients were treated symptomatically only and did not receive a course of Praziquantel. These 
patients were all reviewed retrospectively. Twenty-nine patients (25 children, 4 adults) were 
treated with Praziquantel in addition to the symptomatic therapy. These patients formed part of a 
prospective open therapeutic study (Thomson 1 988). Praziquantel which is a 
pyrazinoisoquinoline derivative provides the first truly broad spectrum antihelminthic agent 
(Mahmoud 1987). 
In both groups the first priority in treatment had been the reduction by, medical means, of 
clinically significant raised intracranial pressure in 30 of these patients ( 13 from the retrospective 
group, 17 from the prospective group). Initially Dexamethasone (Decadron) was given 
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intravenously and then subsequently orally in a dose of 0.5 mg/kg/day in 8 hourly divided doses. 
Five of these patients with severely depressed levels of consciousness had required intravenous 
Mannitol in addition in order to effect a more rapid reduction in the raised intracranial pressure. A 
further 1 2 patients from the prospective group who had not required therapy for symptomatic 
raised intracranial pressure were placed onto Dexamethasone therapy 24-48 hours prior to 
commencing Praziquantel. 
All in all 42 patients were treated with Dexamethasone for varying periods of time. Potassium 
supplements were given to all patients on steroid therapy. In the prospective study group, 
Dexamethasone was continued at a dosage of 0.5 mg/kg/day for the full two weeks of 
Praziquantel therapy, then reduced to 0.25 mg/kg/day for the subsequent 7 days before changing 
to Prednisone 1 mg/kg/day in divided doses. Prednisone was then gradually tapered and tailed 
off as soon as possible. The change to Prednisone was effected as the half-life of 
Dexamethasone is long and it may therefore be difficult to wean patients off Dexamethasone 
after therapy lasting more than a few days. Our previous experience with steroid therapy in 
children with multifocal cysticercal encephalitis had highlighted the difficulty of weaning some of 
these patients off the steroids (Thomson et al 1984). 
Praziquantel was administered to 29 patients with multifocal cysticercal encephalitis as a single 
14 day course at a dosage of 50 mg/kg/day given in three divided doses. Prior to commencing 
therapy all these patients had the following investigations done: CT scans, chest x-rays, 
intradermal Mantoux tests, full blood counts, erythrocyte sedimentation rates, serum chemistries, 
electroencephalograms and lumbar punctures when this procedure was considered safe. Where 
possible cysticercus antibody tests were performed on blood and cerebrospinal fluid. All these 
tests were repeated serially after about 1 month, 3 months, 6 months, 9 months and 1 year in all 
compliant cases. 
In addition to Praziquantel, steroids and anti convulsant therapy, 9 patients received anti-
tuberculous drugs because of strongly positive intradermal Mantoux tests. One patient was 
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treated with antifungal drugs because of probable cryptococcal meningitis and 2 patients received 
a course of antibiotics for a urinary tract infection in one and diarrhoeal disease in the other. 
RESULTS 
Steroid therapy 
Forty two of the 50 patients were treated with steroids. Steroid therapy was discontinued within 
8 weeks in 24 patients ( 10 of the restrospective group and 14 of the prospective group), within 
16 weeks in 9 patients ( 1 retrospective group, 8 prospective group), within 24 weeks in 7 
patients (2 retrospective group, 5 prospective group) and only after 24 weeks in 2 prospective 
group patients. However, one of these last 2 patients required placement of a lumbar peritoneal 
shunt before steroids could be withdrawn. All the patients on steroid treatment developed 
varying degrees of Cushingoid facies and truncal obesity but manifested no serious complications 
such as hypertension, diabetes mellitus or electrolyte abnormalities. However, one patient did 
develop uncontrollable infection, related to prolonged high dose steroid therapy given for his 
cerebral oedema prior to diagnosis and admission. On completion of his two week praziquantel 
course he developed an 'acute abdomen' and only after about 36 hours of illness did he develop 
the rash of varicella. Despite belated acyclovir therapy he died and at autopsy the findings were 
those of disseminated chicken pox lesions in addition to the many degenerating cerebral 
cysticerci. 
Praziquantel therapy 
In none of the 29 patients treated with Praziquantel were any toxic effects noted in haematologic, 
hepatic and renal function during or following on Praziquantel therapy. Likewise no abnormalities 
of glucose, calcium and phosphorus metabolism were noted. A few of the patients on 
concomitant tuberculous therapy developed mild elevation of hepatic enzymes but not severe 
enough to warrant withdrawal of the anti-tuberculous drugs. However, within the first 3 to 5 
days of commencing Praziquantel therapy six patients developed a significant acute pyrexial 
illness with severe myalgia - arthralgia, general malaise and an exacerbation of headache, 
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GRAPH 8 : Clinical Features and C.T.; 21 Patients Symptomatic RX 
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vomiting and drowsiness. In two of these patients the associated ocular palsies were 
exacerabated. This illness resembled a Herxheimer reaction with clinically apparent increases in 
intracranial pressure. The addition of antipyretics and analgesics to the therapy partially 
improved the symptomatology. As the symptoms and signs of raised intracranial pressure 
stabilised the dose of Praziquantel was not reduced and other more active attempts to reduce 
intracranial pressure were not required. These symptoms all gradually improved over the 
subsequent week. 
Clinical Picture and CT Scan Follow-up 
Retrospective Group 
Of the 21 patients (19 children, 2 adults) who were treated symptomatically and did not receive a 
course of Praziquantel, only 7 (6 children, 1 adult) were followed after their initial presentation. 
Their subsequent course is shown in Graphs Ba-e where the clinical features and CT scan 
findings are depicted. 
Early follow-up :- Fourteen patients did not return following discharge. Ten of these had 
cerebral oedema with features of raised intra-cranial pressure which were well controlled 
by corticosteroid therapy. They were well at discharge and were on treatment schedules 
of reducing steroid dosage. The steroid therapy was to be gradually withdrawn by the 
referring doctors. 
Four children were followed between 1-4 months and 2 of these again at 5-7 months 
post admission. All 4 children had features of cerebral swelling on radiologic study (2 on 
ventriculography and 2 on CT). Three presented with clinical features of raised intra-
cranial pressure and two of these had markedly decreased levels of consciousness. The 
fourth was admitted in status epilepticus without clinical evidence of raised intracranial 
pressure. Except for the latter the other 3 all demonstrated fluctuating signs and 
symptoms of raised intra-cranial pressure (related to attempts at steroid withdrawal) for a 
period of 3-4 months in 1 patient and for periods of 4-5 months and 5-6 months 
respectively in the other 2. CT scans done at monthly intervals in 1 of these patients 
showed varying degrees of cerebral oedema. Subsequent to 4 months 2 were discharged 
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GRAPH 9 : Clinical Features and C.T. 29 Praziquantel RX 
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well and subsequent to 5 and 6 months the other two were also discharged well. All of 
these 4 patients at the time of discharge were no longer on steroid therapy. 
Late follow-up:- Three of these early follow-up children subsequently failed to return but 1 
who had presented prior to the availability of CT scanning at Groote Schuur Hospital 
returned 1 year later with problems of epilepsy and dementia. CT scan done at this visit 
demonstrated multiple 'granulomata'. He was seen subsequently at 2 years, 3 years and 
4 years after his original admission. His clinical picture was that of a static 
encephalopathy with mental retardation but easy to control seizures. His sequential CT 
scans were all identical demonstrating multiple calcific foci. 
Two further children and one adult who all had clinical features of raised intra-cranial 
pressure and cerebral oedema on CT scan initially but were well on discharge were only 
seen again at 2 years, 4 years and 7 years respectively. The 2 children returned with a 
history of epilepsy and status epilepticus whereas the adult returned because of an 
intercurrent illness and was neurologically asymptomatic. All 3 demonstrated multiple 
calcific foci on CT scan. 
So the 4 patients seen at follow-up after some years all had multiple calcific foci on CT 
scan although the clinical picture was varied. One with the longest follow-up was 
asymptomatic, 1 was epileptic with frequent seizures, 2 were demented ( 1 with easy to 
control epilepsy and 1 with frequent seizures). 
Prospective Group 
Of the 29 patients (25 children, 4 adults), who were treated with Praziquantel in addition to 
symptomatic therapy, 18 children and 3 adults had symptoms and signs of raised intracranial 
pressure. However, all 29 patients had generalised or multifocal oedema on CT scan with, in 
addition, multiple 'granulomata' in 20 children and 1 adult and multiple enhancing cysts in the 
remaining 3 adults. Their subsequent course is shown in Graphs 9a-f where the clinical features 
and CT scan findings are depicted. 
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Early follow-up:- At the 1-2 month follow-up 9 children and 1 adult had clinically 
improved with resolution of the signs of raised intra-cranial pressure and marked decrease 
in the amount of cerebral oedema on CT scanning. Two children and 1 adult had not 
returned for follow-up but had been clinically well on discharge. 
By the 5-7 month follow-up period the problems of fluctuating raised intra-cranial 
pressure and fluctuating cerebral oedema on CT scan (in relation to attempts at steroid 
withdrawal) had been resolved in 5 of the remaining children. However, two young girls 
were still plagued by steroid dependent cerebral oedema causing significant morbidity six 
months after admission and initiation of therapy. The problem was of such magnitude in 
one of these girls that a lumbar peritoneal shunt was placed before steroids could 
gradually be withdrawn. 
Late follow-up:- Two children were followed until 10 months post admission. One was 
demented and epileptic with a CT scan demonstrating multiple enhancing granulomas plus 
multiple calcific foci. The other was asymptomatic and had a normal CT scan. At the 
12-16 month follow-up 13 children were seen. Eight were asymptomatic and 5 had 
epilepsy. Of the 13 CT scans 11 showed multiple intra-cranial calcific foci (3 of these 
had in addition ventricular dilatation), 1 showed enhancing granulomas and calcific foci 
and 1 was normal. 
EEG and Epilepsy Follow-up: 
Serial follow-up EEG's were obtained in 4 children from the retrospective group of 21 patients 
and in 19 children and 2 adults from the prospective group of 29 patients. 
Retrospective Group 
The 4 from the retrospective group had diffusely slow EEG's on·admission. One of these EEG's 
had returned to normal by 5 months and the others remained diffusely abnormal at 4 months, 2 
years and 4 years when these patients were respectively last seen. 
Prospective Group 
The 21 patients from the prospective group were found to have diffusely slow EEG's in 18 and 
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normal EEG's in 3 patients. 
Of the patients with diffusely abnormal EEG's 8 had reverted to normal by 4-6/12 but 3 
were again abnormal on longer follow-up (2 diffuse slow, 1 focal abnormality). Ten 
remained persistently abnormal with diffuse slowing and 3 of these developed in addition 
persistent focal abnormalities. 
The 3 patients with initial normal EEG's had all developed diffuse slowing at 3/12 follow-
up. 
At 12-16 months, 11 of the patients who were still attending follow-up had EEG's. Five 
of the EEG's were normal, 4 showed diffuse slowing and 2 showed focal abnormalities. 
Initially forty-two patients from both groups were treated with anticonvulsants. The initial 
therapy was Phenobarbitone in 35 patients (all almost exclusively childen), Phenytoin in 4 
patients (all adults) and Carbamazepine in 3 children. Due to inadequate seizure control in 13 
patients Phenytoin was added to the primary therapy in 6 of them, Carbamazepine in 4 of them, 
Clonazepam in 2 and Primidone in 1 . In most of the children the seizures were effectively 
controlled by the initial drug therapy and by the measures employed to reduce intra-cranial 
pressure. 
At the long-term follow-up of more than 12 months 17 patients were reviewed. These 17 
patients consisted of 16 children and 1 adult with 13 coming from the prospective group while 4 
came from the retrospective group. Seven (5 prospective and 2 retrospective) still complained of 
recurrent seizures despite therapy. Their compliance as regards drug therapy was difficult to 
assess. Of the 1 0 patients who were now seizure free 4 had not been taking anti-convulsant 
therapy for some time while the other 6 were well controlled on therapy. 
CSF follow-up: 
Retrospective Group 
The CSF's from 19 of the retrospective group of patients were examined during their initial 
admission. Five and 14 were found to be normal and abnormal respectively. 
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Only 3 patients, all from the abnormal group had repeat CSF studies done. Two of these 
CSF's were still found to be abnormal, in one case at the 1-2 months follow-up and in the 
other at the 5-7 month follow-up. CSF in the 3rd patient had reverted to normal by the 
5-7 months follow-up. 
Prospective Group 
Twenty six patients from the prospective group had CSF studies done during their initial 
admission. 
Ten of these patients were found to have normal CSF's. From amongst these 10 patients 
2 did not return after initial discharge. One patient at 5-7 months follow-up still had a 
normal CSF but then subsequently failed to return as did 2 patients with normal CSF's 
following the 8-1 0 months follow-up and 4 patients with normal CSF' s following the 1 2-
16 months follow-up. Only one patient demonstrated conversion of the CSF to abnormal 
both at the 1-2 months and 2-4 months follow-ups. 
Sixteen patients had abnormal CSF findings on initial admission. Four of these patients 
failed to return. Amongst the others the CSF's remained persistently abnormal in 9 until 
they absconded from follow-up which was after the 1-2 months visit in 3 patients, after 
the 2-4 months visit in 1 patient, after the 8-10 months visit in 2 patients and after the 
12-16 months visit in 3 patients. The CSF findings in the other 3 patients fluctuated 
from normal to abnormal as demonstrated in Table 6. 
TABLE 7: CSF FINDINGS - FOLLOW UP 3 PATIENTS 
Patient 1 
Patient 2 
Patient 3 
ADMISSION 1-2/12 2-4/12 
Abnormal Abnormal 
Abnormal 
Abnormal 
Normal 
Normal Abnormal 
Abnormal Abnormal 
5-7 /12 
Abnormal 
Abnormal 
8-10/12 12-16/12 
Abnormal 
Normal 
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TABLE 8: SEQUENTIAL BLOOD ANTIBODY TITRES IN 12 CHILDREN TREATED WITH PRAZIQUANTEL 
0 0 
1 /12 0 
3/12 +++ 
6/12 0 
9/12 0 
12/12 +++ 
2 3 
+++ +++ 
+++ 0 
0 +++ 
0 +++ 
0 0 
+++ 0 
5 titres 1 S 0 
(In Status Quo) 
4 
0 
0, 
+++ 
0 
+++ 
0 
5 6 
+++ +++ 
0 0 
+++ 0 
0 +++ 
0 0 
+++ -
PATIENTS 
7 
+++ 
++ 
+ 
0 
0 
0 
4 titres I 
8 9 
++ 0 
+ 0 
0 + 
+ ++ 
0 
0 0 
TABLE 9: SEQUENTIAL CSF ANTIBODY TITRES IN 11 CHILDREN TREATED WITH PRAZIQUANTEL 
2 3 4 
0 +++ +++ ++ 0 
1/12 +++ 0 0 + 
3/12 0 +++ 0 ++ 
6/12 0 0 +++ 0 
9/12 0 0 0 0 
12/12 +++ 0 +++ 0 
2 titres 1 SO 3 titres I 
5 6 
++ +++ 
0 
+++ + 
0 
0 0 
0 0 
PATIENTS 
7 
+++ 
0 
+ + + 
+ + 
0 
0 
8 9 
0 ++ 
0 0 
+++ 0 
0 0 
++ 0 
0 -
5 titres I 
TABLE 10: SEQUENTIAL BLOOD ANTIBODY TITRES IN 2 CHILDREN NOT TREATED WITH 
PRAZIOUANTEL 
PATIENTS 
2 
0 +++ 0 +++ 
1/12 0 1 /12 0 
3/12 0 3/12 0 
6/12 + 6/12 0 
12/12 12/2 +++ 
10 11 12 
++ + -
0 0 -
++ +++ -
0 0 0 
0 0 0 
+++ 0 ++ 
3 titres I 
10 11 
+++ -
0 -
0 0 
0 
0 0 
- -
1 titre -ve 1 SO 
CSF Eosinophilia follow-up 
Prospective Group 
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Special staining for eosinophils was only done on the CSF's of 11 patients prior to treatment with 
Praziquantel. 
Four of these CSF's stained positive for eosinophils. Only 1 of these 'positive' patients 
had further CSF's examined and these were repeatedly positive for eosinophils at 1-2 
months, 5-7 months and 8-10 months. 
Two patients whose CSF' s were initially negative for eosinophils became positive 
subsequent to Praziquantel therapy at 2-4 months in 1 patient and at 5-7 months in the 
other patient. In the latter patient the CSF eosinophilia had cleared by the 12-16 month 
follow-up. 
In 5 patients the CSF's were only examined for eosinophils after Praziquantel therapy had been 
commenced. 
In only one of these CSFs was eosinophils found. This cerebrospinal fluid no longer 
demonstrated the presence of eosinophils at the 8-1 0 month visit. 
Retrospective Group 
Amongst the patients not treated with Praziquantel 2 of the 6 CSF's examined at the initial 
presentation were found to contain eosinophils. One of these reexamined at the 1-2 month 
follow-up was still positive. Two further patients whose CSF's were examined after the initial 
presentation were not found to contain eosinophils. 
Follow-up of Immunological tests: 
Table 8, 9 and 10 delineate the sequential titres of antibody to cysticercus antigen in the blood of 
12 children treated with Praziquantel, in the CSF of 11 children treated with Praziquantel and in 
the blood of 2 children not treated with Praziquantel. Although these sequential titres are by no 
means complete no definite pattern could be determined following treatment with Praziquantel. 
Some patients showed no change in antibody titres, others showed an increase in the titres and 
yet others showed a decrease in the titres. Similarly one of the patients not treated with 
Praziquantel showed a decrease in the titres at follow-up and the other showed no change in the 
TABLE 11: 
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AGE/SEX DISTRIBUTION MUL TIFOCAL CYSTICERCAL ENCEPHALITIS 
RETROSPECTIVE AND PROSPECTIVE GROUPS 
NO OF PATIENTS 
AGE DISTRIBUTION RETROSPECTIVE PROSPECTIVE 
0-3 years 
4-6 years 
7-9 years 
10-12 years 
13-15 years 
16-20 years 
20-25 years 
25-30 years 
14 
7 
2 
8 
5 
4 
0 
1 
0 
1 
male 
female 
3 
12 
8 
2 
1 
1 
1 
1 
10 male 
19 female 
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titres at follow-up. 
Summary of Clinical Follow-up 
In summary 2 patients died during their admission. One adult from the retrospective group died 
shortly after admisison from cryptococcal meningitis. No autopsy was done. The other a child 
from the prospective group died from disseminated chicken pox following on prolonged high dose 
steroid therapy. Forty one patients were assessed as being clinically improved when last seen -
15 (11 retrospective, 4 prospective) at 0-2 months, 12 (3 retrospective, 9 prospective) at 3-6 
months, 1 prospective at 6-9 months and 13 (2 retrospective, 11 prospective) at more than 1 
year. It is important to note that the number of clinically improved patients recorded at the above 
intervals is related to the time of discharge and not to the time of initial clinical improvement. 
Five patients were assessed as being clinically in status quo when last seen - 2 retrospective at 
0-2 months, 1 prospective at 6-9 months and 2 prospective at more than 1 year. Two patients, 
both retrospective were assessed as having deteriorated clincally at long-term follow-up of more 
than 2 years. 
DISCUSSION 
This study is partly a retrospective one and although the two groups of patients i.e. Praziquantel 
'treated' (prospective) and 'untreated' (retrospective) are with the exception of the sex 
distribution matched in regards to age (Table 11 ), race, clinical presentations and radiologic 
findings, the follow-up number especially of the retrospective cases is too small for adequate 
comparison. Indeed the high drop-out rate of the patients from the prospective open therapeutic 
study exposes the difficulty experienced in conducting long-term follow-up drug trials in 
developing countries. 
Follow-up assessment at 1-4 months of the retrospective patients consisted of only 4 as 
compared to the 26 prospective patients. As all retrospective patients were clinically improved at 
discharge it is possible that only those that became steroid dependent returned for early follow-
up. Three of these retrospective patients manifested a fluctuating encephalopathy which was 
related to variations in steroid dosage as attempts were made to withdraw this therapy. In 1 
case the fluctuating encephalopathy continued for as long as 6/12 post initial admission. 
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Amongst the prospective patients, most of those with the clinical features of raised intra-cranial 
pressure had resolved their clinical problems by 1-2 months but 5 remained with fluctuating 
encephalopathy and cerebral oedema on CT scan for a longer period. Three of these patients 
resolved between 2-4 months while another 2 only resolved between 5-7 months. Of note one 
of the latter 2 patients had not resolved adequately and was judged to require a lumbar-peritoneal 
shunt at 6/12 because of recurrent severe symptomatic cerebral oedema. Of interest the 3 most 
ill cases in the prospective group were females whereas in the retrospective group the two most 
ill cases where males. This finding does not confirm the observations of others that the most 
marked inflammatory reactions invoked by the parenchymal parasite occur in females (Rangel et 
al 1987; Del Brutto et al 1988). 
Although early deaths among the 'rapid responders' of the retrospective group cannot be 
excluded, it might be reasonable to presume that the majority of these patients followed the same 
course as those who responded more rapidly amongst the prospective group. The marked 
variation in the time to resolution of symptoms and in particular the fluctuation in the degree of 
the cerebral oedema on CT scan of steroid treated patients with multifocal cysticercal encephalitis 
has been commented on previously (Rangel et al 1987; Carbajal et al 1983). It seems therefore 
that in the early follow-up of patients with serve multifocal cysticercal encephalitis the addition of 
Praziquantel to the therapy does not appear to lessen the severity or the duration of the acute 
encephalopathic illness in these patients. In fact in some patients the addition of Praziquantel 
exacerbated their symptoms transiently despite 'adequate' steroid cover. This possible 
exacerbation of symptoms would be expected and has often been previously documented (Wadia 
et al 1988; Sotelo 1987). 
In cases of multifocal cysticercal encephalitis with symptomatic raised intra-cranial pressure the 
mainstay of therapy is cortisone. Therefore there can be little argument about prophylactic 
steriod use when Praziquantel therapy is contemplated in these patients even if they do not have 
overt raised intra-cranial pressure. However, the use of prophylactic steroids prior to 
commencing and during Praziquantel therapy in neurocysticercosis is a controversial issue. Some 
authorities maintain that it is mandatory to use steroids in conjunction with Praziquantel therapy 
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as the dangers of increased inflammation and cerebral oedema are significant (De Ghetaldi et al 
1983; De Ghetaldi et al 1984; Ciferri 1 984). Others have shown, that it is not necessary to use 
prophylactic steroids in all patients with neurocysticercosis on Praziquantel therapy and 
recommend that steroids be used only if the patients develop significant symptomatic cerebral 
oedema (Sotelo 1987). Also the use of steroids in conjunction with Praziquantel has been shown 
to lower the serum levels of the latter (Vasquez et al 1987). Whether this impairs the therapeutic 
efficacy of Praziquantel is not known but in the light of the following report the loss of efficacy 
appears to be doubtful. A report on 2 patients treated with Praziquantel and Prednisone daily for 
3 weeks demonstrated that Praziquantel still penetrated rapidly into the CSF despite the 
concomitant use of steroids. It entered the parasite more slowly but still more rapidly than the 
plasma half-life of the drug (Overbosch et al 1987). 
When comparing the late follow-up of retrospective and prospective patients there is the same 
problem as mentioned above. Only 4 of the retrospective patients were followed for 2 or more 
years post-admission. All 4 had similar CT scans findings i.e. multiple calcific foci, but they had 
variable clinical outcomes. One patient was well and asymptomatic while 3 were epileptic, two 
of whom had bouts of status epilepticus and 2 of whom were demented. Thirteen patients of the 
prospective group were followed for 12-1 6 months. Eleven showed the presence of multiple 
calcific foci on CT scan while 1 in addition showed occasional enhancing 'granulomata' and one 
had a normal CT scan. Eight of these patients were reported to be asymptomatic while 5 still 
complained of recurrent seizures. As the length of follow-up was not the same and the numbers 
of retrospective patients too small it is impossible to arrive at any valid conclusions. However, it 
does not appear that there was any great difference in the long-term outcome of the two groups 
especially if it is noted that one prospective patient who failed follow-up after 10 months was 
both demented and epileptic. No specific pattern of change following Praziquantel therapy was 
definable in the serial CSF findings and in the serial antibody titres in both blood and CSF. It is 
difficult to draw any conclusions from the serial electroencephalographic findings except to note 
c. CT scan (with contrast) demonstrates 
marked reduction in the number of 
enhancing granulomata 6 months 
after Praziquantel treatment 
d. CT scan (with contrast) is now almost normal 
with very occasional granulomata still present 
12 months after Praziquantel treatment 
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Radiology 14 
CT scans of a child with multifocal 
cysticarcal encephalitis 
a. CT scan (with contrast) 
demonstrates multi -focal 
oedema with ring enhancing 
lesions at initial presentation of 
patient 
b. CT scan (with contrast) 
demonstrates multi -focal 
homogeneously enhancing 
lesions 3 months after 
Praziquantel therapy 
Radiology 15 
CT scan demonstrates atrophy and multiple calcific 
foci. This was the end result of multifocal cysticercal 
encephalitis 1 year after initial admission (refer 
earlier CT scans of same patient Radiology 10 and 
11 ). 
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that the presence and degree of bilateral slowing was related to the presence of diffuse cerebral 
oedema and encephalopathy. The EEG abnormality improved with Decadron therapy but in the 
prospective group was occasionally exacerbated by Praziquantel therapy in these patients. The 
EEG findings at the 12-16 months follow-up in the prospective group show no specific trend. 
The initial clinical response in both groups was due to the reduction of cerebral inflammatory 
oedema with the use of steroids. The clinical course and outcome of the few comparable cases 
in both groups was very similar as were the CT changes which have been described (Handler and 
Mervis 1983). Initial multifocal oedema with or without ring enhancing lesions evolves at a 
varying speed over a period of 2-7 months into enhancing miliary lesions with decreasing 
surrounding oedema. These enhancing lesions gradually decrease in intensity and may disappear 
by 10-12 months or more usually be gradually replaced by radiologically detectable calficic 
lesions from 12 months onwards (Radiology 14 a-d and Radiology 15) . 
The lack of demonstrable therapeutic effect is probably to be expected in this form of the 
disease. In our experience and in the experience of others this is most unlike the findings in 
some adult patients with other forms of the disease. These particular adults present with non-
enhancing parenchymal cysts on MRI or CT scan and when treated with Praziquantel rapidly 
develop a pericystic inflammatory-allergic response which manifests on MRI or CT scan as 
contrast rim enhancement of the cysts (Radiology 16 a-c). These enhancing cysts then 
depending on their size disappear at variable rates and might or might not be replaced by calcific 
foci ( Vascoucelos et al 1987; Robles et al 1987; Sotelo et al 1984; Sotelo et al 1985; Joubert 
and Van As 1990) . The parasitocidal effect of Praziquantel has been well shown in a number of 
different parasitic diseases including neurocysticercosis and has firmly established Praziquantel as 
the first truly broad spectrum anti--parasitic drug (Mahmoud 1987) . It should be noted however 
that spontaneous evolution and healing of 'parenchymal' parasitic cysts may occur and has been 
documented (Miller 1983b) . It has also become clear from our experience and from that of 
others that the cysts in the ventricles and to a lesser extent those in the larger subarachnoid 
spaces are not usually damaged by Praziquantel and persist despite repeated courses of the drug 
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b. MRI (with gadolinium) 3 days after commencing 
Praziquantel therapy. Many cysts now demonstrating 
marked rim enhancement 
Radiology 16 
MRI of an adult patient with parenchymal cysts 
a. MRI (with gadolinium) prior to Praziquantel 
therapy demonstrating minimal or non-
enchancement of the cysts. 
c. MRI (with 
commencing 
demonstrates 
enhancement. 
gadolinium) 7 days after 
Praziquantel therapy 
further increase of rim 
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(Sotelo 1988; Sotelo and Del Brutto 1987, Joubert 1990). 
In the young patients presenting with multifocal cysticercal encephalitis, the triggering factors 
responsible for the host's inflammatory response are already operative. Therefore it has been 
suggested that the use of Praziquantel in these patients is perhaps rendered unnecessary or even 
dangerous. This latter suggestion is leant credence by a report from India of a small series of 
patients with severe extensive disseminated cysticercosis. These very ill patients had serious 
even fatal reactions due to 'massive cyst breakdown' following on Praziquantel therapy despite 
steroid cover (Wadia et al 1988). A report from Hong Kong also highlights the possible danger of 
Praziquantel therapy in these heavily infested patients. A patient with extensive neural parasitic 
cysts developed cerebral infarction following on Praziquantel therapy, again despite steroid cover 
(Woo et al 1988). This however has not been our experience. The use of high dose steroid 
cover has apparently successfully suppressed the more serious complications caused by the 
extensive inflammatory response in our patients whether it was spontaneous or Praziquantel 
induced. 
The suggestion that the use of Praziquantel is unnecessary in cases of focal or multifocal 
cysticercal encephalitis is supported by the experience gained in California. It was, however, 
pointed out that their patients were not as ill or as extensively infected as those from the Third 
World regions (Mitchell and Crawford 1988; Goldberg 1984). In this present series the small 
numbers of patients with multifocal cysticercal encephalitis who were not treated with 
Praziquantel and who were followed for long enough seemed to have the same clinical and 
radiological outcome as those followed from the Praziquantel group. The outcome of both of 
these groups is perhaps comparable to the quoted experience of the few similar though less ill 
patients who were followed in California (Mitchell and Crawford 1988). 
The use of Praziquantel for the treatment of 'intraparenchymal cysticercosis' has also been 
queried following on the experience gained by some investigators in Natal, South Africa. In these 
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Radiology 17 
CT scans (with contrast). Different views of the same 
patient demonstrating the presence of non-enhancing cysts, 
enhancing cysts, occasional granulomata and calcific foci 
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authors experience this form of the disease is usually self-limited (Moodley and Moosa 1989). 
However, this is strongly at variance with the opinion based on the experience of others from 
Natal (Van Dellen and McKeown 1988). It must be reemphasised that it is important to 
differentiate between patients with CT findings of non-enhancing parenchymal cysts and patients 
with CT findings of cysticercal encephalitis (Mitchell and Crawford 1988). The former are found 
in adult patients and occassionally in adolescents and not in children in our experience. These 
cysts may persist for many years growing to large sizes with possible space demanding effects. 
With the onset of spontaneous inflammation in these cysts the risk of increasing mass effect and 
of serious complications developing prior to resolution is a very real one. These cysts are 
however very sensitive to destruction by Praziquantel, with a rapid onset of the inflammatory 
response following on initiation of therapy. Thus if the 'natural history' of cyst resolution can be 
hastened while under medical surveillance presumably the risk of complications developing prior 
to that resolution will be much reduced. Therefore, their seems to be a good reason for the use 
of Praziquantal in this 'parenchymal' cystic form of the disease. However, the presence of 
cysticercal encephalitis with either enhancing cysts or with enhancing 'granulomata' indicates 
that the parasites are already damaged and therefore do not require Praziquantel therapy to 
hasten their destruction and resolution. 
Some authorities however still recommend Praziquantel therapy for patients with multifocal 
cysticercal encephalitis (Vascoucelos et al 1987; Sotelo and Del Brute 1987). In support of this 
recommendation a number of observations are worth noting. Firstly, at any one time some 
patients are infested with parasites at markedly different stages of their life cycle. On the CT 
scans of some children coexistence of patches of oedema, 'granulomata' and calcific foci have 
been observed. In adolescents and adult patients some CT scans have shown the coexistence of 
non-enhancing cysts, enhancing cysts, granulomata with oedema and calcific foci (Radiology 1 7). 
These CT scan findings suggest that either the patient has had a number of episodes of exposure 
to the parasite or that if only a single exposure occurred, not all the cysts mature at the same 
rate and become vulnerable to the hosts' defences at the same time. Secondly, in some of these 
patients with multifocal cysticercal encephalitis addition of Praziquantel to the therapeutic 
b. Demonstrating increased numbers of 
granulomata with marked increase of 
white matter oedema following on 
Praziquantel therapy. Note enhancement 
of left frontal cyst 
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Radiology 18 
CT scans (with contrast) of the same 
patient: 
a. demonstrating the presence of 
enhancing granulomata, with 
minimal oedema prior to 
Praziquantel therapy. Occa-
sional frontal cysts present 
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programme resulted in a severe exacerbation of the symptoms and signs suggesting that there 
was an increase in cyst destruction and in the amount of cysticercal antigen being released 
following the cysticidal effects of the Praziquantel (Radiology 18). Thus it appears that even in 
these patients, with the development of marked spontaneous inflammatory reactions during the 
natural course of events, not all the cysticerci become vulnerable at the same time. Thirdly, a 
few of these patients who gave a history of prolonged or recurrent bouts of encephalopathy had 
associated prolonged status epilepticus and survived with residual cognitive dysfunction as a 
result of their hypoxic-ischaemic damage. Hopefully the complication of prolonged status 
epilepticus could be avoided if the patients were under medical supervision at the time of cyst 
destruction and encephalopathy. 
Although there is no conclusive evidence that Praziquantel is effective or even necessary in 
patients with multifocal cysticercal encephalitis we have continued to treat such patients with 
Praziquantel despite the unresolved controversies. It is therefore suggested, that even in the 
presence of encephalitis, 'parenchymal' cysticerci be treated by Praziquantel under controlled 
conditions in hospital (Thomson 1 990). This may ensure that the parasites may all be destroyed 
at the same time and thus perhaps the occasional spontaneous development of severe 
sequaelae be avoided or at least treated appropriately in the hospital situation. Of note those of 
our multifocal encephalitic patients with obvious severe dementia had had episodes of 
encephalopathy with status epilepticus prior to admission and therapy. 
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PARTV 
CONCLUSIONS 
1. The majority of the patients in this study were Africans. With few exceptions they 
originated from amongst the Xhosa speaking people of the eastern regions of the Cape 
Province. This high incidence of neurocysticercosis amongst the Xhosa people has been 
noted previously (Campbell and Farrell 1987). The patients came from socio-economically 
deprived rural communities. The practice of free range pig farming associated with the 
lack of sanitation and poor education amongst these people renders their homelands one 
of the largest endemic cysticercal regions in South Africa. For the foreseeable future 
eradication of the disease by preventative measures such as education, improved 
sanitation and improved farming methods is unlikely to be attained rapidly in the present 
socio-economic climate. 
2. Amongst these symptomatic patients with neurocysticercosis epilepsy was by far the 
commonest presenting symptom. This has frequently been the finding in other series 
(Subianto et al 1978; Arseni and Cristesau 1972; Powell et al 1966; MacArthur 1934; 
Bittencourt et al 1988; Campbell and Farrell 1987; Naidoo et al 1987). Seizures as an 
isolated neurological problem occurred as commonly amongst the children as amongst the 
adults, however, seizures plus other neurological complications were much more 
frequently found amongst the children. Therefore, the following axiom applies, that any 
patient from an endemic area who presents with a neurological problem in particular 
epilepsy should be regarded as having neurocysticercosis until proven otherwise. 
3. The next most common neurological manifestation of neurocysticercosis in these patients 
was that of raised intra-cranial pressure. A large number of the patients were children 
and 40.6% of the children presented with features of raised intra-cranial pressure either 
clinically or radiologically. Of these 88% were found to have multifocal cysticercal 
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encephalitis whereas only 12% were found to have hydrocephalus. These findings are in 
direct contrast to the findings amongst the adult patients with raised intra-cranial 
pressure. These adults comprised 31 % of the total adult group and whereas 73.3% 
presented with hydrocephalus only 16.6% had multifocal encephalitis and 11.1 % had 
focal cystic space demanding lesions. This marked difference in the pathology of intra-
cranial hypertension due to neurocysticercosis in adults and children has been 
documented previously (Hernandez and Garaizar 1982a). 
4. In our experience multifocal cysticercal encephalitis is a very serious illness and gives rise 
to significant morbidity. Although none of these patients died due to the effects of the 
disease case fatalities are not infrequent (Rangel et al 1987). The raised intra-cranial 
pressure produced by the disease may be critical and give rise to transtentorial herniation 
which presumably because of the aggressive medical therapy did not end fatally in these 
patients . The added complication of status epilepticus in many of these patients 
increases the already dangerously raised intra-cranial pressure and may produce further 
anoxic-ischaemic damage to the brain with mental retardation as a result. 
5. Most of these patients with multifocal cysticercal encephalitis require admission to 
hospital for treatment of their significant intra-cranial pressure problems. Steroid therapy 
is quite dramatic in its ability to reduce inflammation and cerebral oedema in these 
patients with rapid improvement in their symptomatology. A few patients with early 
transtentorial herniation had to be given Mannitol as well. Although there is an initial 
good response to steroid therapy in these patients a few of them developed a prolonged 
degree of steroid dependence. 
6. In our patients with raised intra-cranial pressure due to cysticercal encephalitis the CT 
scan demonstrated the presence of many parasitic lesions. No patients with diffuse 
cerebral oedema on CT scan were found to have only single or infrequent parasitic 
lesions. Therefore, to some extent the severity of the cerebral oedema depends on the 
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number of the infesting parasites. Why in some patients the parasite loses its ability to 
evade the hosts immune system and thus invokes a massive inflammatory response in the 
host is largely unknown. However, this presumably depends to some extent on the 
competence of the hosts immune system. We have not found that females are more 
likely than males to develop a more severe form of cysticercal encephalitis. 
7. The course ~nd outcome of the patients with multifocal cysticercal encephalitis who were 
treated with Praziquantel was very similar to that of the few followed from the 
retrospective group and to the experience previously reported in the literature (Thomson 
et al 1984; Mitchell and Crawford 1988). Praziquantel produces its therapeutic effect by 
damaging the viable 'quiescent' cysts which had previously evaded the hosts immune 
system. These damaged cyst capsules then can no longer continue to evade the host 
inflammatory response. However, in patients with cysticercal encephalitis the 
inflammatory response has already been initiated spontaneously and therefore the addition 
of Praziquantel to therapy is probably unlikely to make any obvious difference to the 
outcome. A carefully controlled drug trial is the minimum prerequisite for the assessment 
of drug efficacy in a disease process, especially when the natural history of the disease is 
as variable and is as inadequately documented as in neurocysticercosis. However, the 
difficulty of conducting controlled double blind drug trials in third world populations is 
well recognised and has again been highlighted by the incomplete follow-up of the 
patients in the trial described in Part IV of this dissertation. 
The parasitocidal efficacy of Praziquantel in adult and adolescent patients with 
'parechynmal' cysts has been well documented and therefore its use in selected patients 
is indicated. Perhaps some of these patients with small numbers of non-life threatening 
cysts could be carefully followed in the absence of Praziquantel therapy so as to observe 
the natural history of this form of the disease. On the other hand Praziquantel has in our 
experience and that of others (Joubert 1990) been shown to be ineffective in the therapy 
of intraventricular and subarachnoid racemose cysts and may even be contraindicated in 
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some of the latter cases. 
The decision whether or not to use Praziquantel in patients with cysticercal encephalitis is 
not clear cut. In the absence of a properly controlled double-blind drug trial an attempt to 
trace more of these patients for late follow-up assessment may provide a clearer answer 
to the natural history and to the indications for use of Praziquantel in patients with 
multifocal cysticercal encephalitis. 
8. However, for a number of reasons we have continued to treat with Praziquantel those 
patients who have multifocal cysticercal encephalitis: 
a. Praziquantel and subsequently Albendazole have been shown to be effective in 
the treatment of neurocysticercosis (Sotelo et al 1988; Alarcon et al 1989) 
(Albendazole is not as yet available in South Africa) 
b. There is no conclusive evidence that all the 'parenchymal' cysts are involved at 
the same time in the spontaneous encephalitic process. Moreover, our experience 
suggests that not all the cysts are involved at the same time in this process. 
There is an exacerbation of symptomatology in some of these patients as well as 
an increase in the size and number of the enhancing lesions and the degree of 
oedema on CT scan following on Praziquantel therapy (Radiology 18). These 
findings therefore suggest than there maybe some quiescent cysts undetected by 
the hosts immune system which are damaged by Praziquantel therapy in these 
patients. 
c. Praziquantel has shown no toxic effects in these patients with regard to 
haematologic, hepatic or renal function. In the patients in this series who 
developed severe Herxheimer reactions after commencing Praziquantel therapy, 
all were well controlled on high dose steroid and no fatalities nor complications 
resulted. If life-threatening complications appear imminent Praziquantel should be 
withdrawn from therapy and possibly recommenced carefully at a lower dosage. 
d. Most if not all of these patients with multifocal cysticercal encephalitis require 
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d. Most if not all of these patients with multifocal cysticercal encephalitis require 
hospitalization and steroid therapy. Therefore the use of Praziquantel or 
Albendazole (which is reported to be relatively inexpensive) would seem to be of 
value under these controlled circumstances. 
Guidelines outlining the indications for Praziquantel or Albendazole therapy have been 
carefully tabulated from years of experience (Sotelo 1987; Sotelo an Del Brutto 1987; 
Sotelo 1988). The need for Praziquantel and/or Albendazole therapy must be carefully 
assessed for each individual patient. Our experience is indeed very similar to that 
reported from South and Central America. 
9. Of course prevention is better than cure. The final solution to the problem of 
neurocysticercosis rests with the education of the affected rural populations and hopefully 
a resultant improvement in their socio-economic status, farming methods and sanitation. 
In countries such as South Africa, endemic cysticercal regions with high rates of 
population infectivity, result in significant costs to the economy. To the high cost of 
hospitalization and medication must be added the economic losses incurred by 
absenteeism from work as well as by the wastage of large quantities of infected 'measly' 
pork. 
It would be appropriate and of some priority to undertake a cost-effective study 
comparing the cost of educating the indigenous people (regarding the life cycle of taenia 
solium and the dangers of neurocysticercosis) with the cost already incurred by the 
existing situation. Should education of the involved communities be found to be a 
feasible economic proposition, it would be of prime importance, to ensure that these 
communities understand, that the disease can in the first instance be largely eradicated by 
prevention of 'free range human defaecation' and by the use of 'pit toilets'. They should 
also understand that pigs should be denied access to such areas and that as their 
economy improves free range pig farming should be replaced by more modern methods. 
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